{
  "sources": [
    {
      "title": "NatureReviewsCancer (@NatureRevCancer) / Twitter",
      "feedUrl": "https://rss.app/feeds/epZdxRZ8KpjwgnkE.xml",
      "siteUrl": "https://twitter.com/NatureRevCancer",
      "articles": [
        {
          "id": "72a3a11d39c217b1a80cbb551444e6f6",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Nodal interferon exposure drives tumour-specific tolerance https://t.co/FT4NeBcFTg pic.twitter.com/NRHkVDUsOr\n‚Äî NatureReviewsCancer (@NatureRevCancer) June 6, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1533878403463405569",
          "publishedOn": "2022-06-06T18:28:04.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Nodal interferon exposure drives tumour-specific tolerance",
          "imageUrl": null
        },
        {
          "id": "bb6bc242bcbc356c4a38db850e74d812",
          "author": "@VIBConferences",
          "description": "#Cancer #immunotherapy has become a crucial pillar of anticancer therapy. 19 leading researchers at #ImmunoOnco22 will give new insights into the immune response to tumors and tackle unresolved questions.\n‚è∞Registration Deadline: Thursday 2 June. Read more https://t.co/cc0HC5cj6W pic.twitter.com/u8LFuzBbsV\n‚Äî VIB Conferences (@VIBConferences) May 30, 2022",
          "link": "https://twitter.com/VIBConferences/status/1531132720952266752",
          "publishedOn": "2022-05-30T04:37:42.000Z",
          "wordCount": 196,
          "title": "@VIBConferences: #Cancer #immunotherapy has become a crucial pillar of anticancer therapy. 19 leading researchers at #ImmunoOnco22 will give new insights into the immune response to tumors and tackle unresolved questions.‚è∞Registration Deadline: Thursday 2 June. Read more",
          "imageUrl": null
        },
        {
          "id": "ed6c996dc1a718afb523de6229a53131",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Nonsense-mediated RNA decay: an emerging modulator of malignancy https://t.co/wjuHplkpof pic.twitter.com/1SoKYhRsPO\n‚Äî NatureReviewsCancer (@NatureRevCancer) May 27, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1530198403686072320",
          "publishedOn": "2022-05-27T14:45:03.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Nonsense-mediated RNA decay: an emerging modulator of malignancy",
          "imageUrl": null
        },
        {
          "id": "d15a3a4b24853812d7fa21fd56de5815",
          "author": "@NatureRevCancer",
          "description": "Our June issue, out NOW! With articles on #therapyresistance, #senescence & targeting CDK4 & CDK6 in #cancer! Plus, a Comment on cancer mRNA vaccines as well as the launch of our new Tools of the Trade articles #NRCToT. So much content üëáüèª\nüíå https://t.co/Fo6XRWV3OZ@natrescancer pic.twitter.com/rbxRPqLV6g\n‚Äî NatureReviewsCancer (@NatureRevCancer) May 27, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1530174481313972224",
          "publishedOn": "2022-05-27T13:10:00.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: Our June issue, out NOW! With articles on #therapyresistance, #senescence & targeting CDK4 & CDK6 in #cancer! Plus, a Comment on cancer mRNA vaccines as well as the launch of our new Tools of the Trade articles #NRCToT. So much content üëáüèªüíå",
          "imageUrl": null
        },
        {
          "id": "fe13755a2693ea65459e5e21df097d2a",
          "author": "@UlrikeHarjes",
          "description": "This Review by @MarcusDGon @cantleylab is part of the @NatureRevCancer series on #Diet & #SystemicMetabolism in cancer: https://t.co/p3Y2cdNhco\nI do love this topic in general plus I am handling research at @NatureMedicine now.. get in touch if you have something of interest‚ò∫Ô∏è https://t.co/qWH2dTv8j9\n‚Äî Ulrike Harjes (@UlrikeHarjes) May 26, 2022",
          "link": "https://twitter.com/UlrikeHarjes/status/1529747629936193537",
          "publishedOn": "2022-05-26T08:53:50.000Z",
          "wordCount": 196,
          "title": "@UlrikeHarjes: This Review by @MarcusDGon @cantleylab is part of the @NatureRevCancer series on #Diet & #SystemicMetabolism in cancer:  do love this topic in general plus I am handling research at @NatureMedicine now.. get in touch if you have something of interest‚ò∫Ô∏è",
          "imageUrl": null
        },
        {
          "id": "9ba5279424b31b0122a4ae20c18e6d03",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Developing dietary interventions as therapy for cancer https://t.co/ijuqctk1wJ pic.twitter.com/KHPpMKnCFa\n‚Äî NatureReviewsCancer (@NatureRevCancer) May 25, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1529516411059437568",
          "publishedOn": "2022-05-25T17:35:04.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Developing dietary interventions as therapy for cancer",
          "imageUrl": null
        },
        {
          "id": "611d40f2e6ea2796b028bebda41a86dd",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Digging for treasures in the tumour interactome https://t.co/NhHYAwUgLE\n‚Äî NatureReviewsCancer (@NatureRevCancer) May 18, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1526928478490095616",
          "publishedOn": "2022-05-18T14:11:32.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Digging for treasures in the tumour interactome",
          "imageUrl": null
        },
        {
          "id": "9590a971b00448cd312078183965b21d",
          "author": "@NatureRevCancer",
          "description": "As part of our overall commitment to diversity, equity and inclusion at Springer Nature, we‚Äôd like to better understand what DEI means within the global research community. Take the survey here https://t.co/03yLiUxFTq\n‚Äî NatureReviewsCancer (@NatureRevCancer) May 17, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1526560254091313156",
          "publishedOn": "2022-05-17T13:48:21.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: As part of our overall commitment to diversity, equity and inclusion at Springer Nature, we‚Äôd like to better understand what DEI means within the global research community. Take the survey here",
          "imageUrl": null
        },
        {
          "id": "aa38ff4245b93e964773f191844ddc7a",
          "author": "@NatureRevCancer",
          "description": "Newsflash! We have a new article type in the journal - Tools of the Trade #NRCToT üß∞ üõ†Ô∏è where we hope to enable more #ECRs to interact with the editorial team & have a bigger voice in our content. For more info, check out the Editorial üëáüèª https://t.co/VbyoUJmTRJ\n‚Äî NatureReviewsCancer (@NatureRevCancer) May 12, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1524772831904509953",
          "publishedOn": "2022-05-12T15:25:46.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: Newsflash! We have a new article type in the journal - Tools of the Trade #NRCToT üß∞ üõ†Ô∏è where we hope to enable more #ECRs to interact with the editorial team & have a bigger voice in our content. For more info, check out the Editorial üëáüèª",
          "imageUrl": null
        },
        {
          "id": "65aca76b9f794aaa668d84ad32dca4a0",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Tools for the next generation https://t.co/lEzTPFYDf5\n‚Äî NatureReviewsCancer (@NatureRevCancer) May 10, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1524068259712036864",
          "publishedOn": "2022-05-10T16:46:03.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Tools for the next generation",
          "imageUrl": null
        },
        {
          "id": "afa9b6784b4ccc7c05ed4efd26ddfb2d",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Hunting down rare drug-tolerant cycling cells with Watermelon https://t.co/XXT0c9SAYX\n‚Äî NatureReviewsCancer (@NatureRevCancer) May 10, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1524022709386190856",
          "publishedOn": "2022-05-10T13:45:03.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Hunting down rare drug-tolerant cycling cells with Watermelon",
          "imageUrl": null
        },
        {
          "id": "43e2d5ccebc9030f737d656f47ac9d98",
          "author": "@VarunVenkatara2",
          "description": "Very happy that our latest Perspective is now online @NatureRevCancer ! We discuss implications of malignant, multicellular networks and potential therapeutic strategies how to disconnect them. Thanks to everyone involved ! #CancerNeuroscience #TumorMicrotubes #neurotwitter https://t.co/S55cKTGNFd\n‚Äî Varun Venkataramani (@VarunVenkatara2) April 29, 2022",
          "link": "https://twitter.com/VarunVenkatara2/status/1520050291986604033",
          "publishedOn": "2022-04-29T14:40:05.000Z",
          "wordCount": 196,
          "title": "@VarunVenkatara2: Very happy that our latest Perspective is now online @NatureRevCancer ! We discuss implications of malignant, multicellular networks and potential therapeutic strategies how to disconnect them. Thanks to everyone involved ! #CancerNeuroscience #TumorMicrotubes #neurotwitter",
          "imageUrl": null
        },
        {
          "id": "9f6b8644378881f4c2e6b6833c93fc2f",
          "author": "@NatureRevCancer",
          "description": "NEW content online! An inhospitable site https://t.co/0dvqIKCWxh pic.twitter.com/PtY8J9Fz7r\n‚Äî NatureReviewsCancer (@NatureRevCancer) April 29, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1520020349068316673",
          "publishedOn": "2022-04-29T12:41:06.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! An inhospitable site",
          "imageUrl": null
        },
        {
          "id": "f6d91efcd60dae769e2722585bdfa8df",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Disconnecting multicellular networks in brain tumours https://t.co/LJrzy8bRma pic.twitter.com/CO7BnooP0r\n‚Äî NatureReviewsCancer (@NatureRevCancer) April 29, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1520020340201598978",
          "publishedOn": "2022-04-29T12:41:04.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Disconnecting multicellular networks in brain tumours",
          "imageUrl": null
        },
        {
          "id": "76e3b436bc8e43ad21366a80c120e395",
          "author": "@NatureRevCancer",
          "description": "Our May issue, out NOW! With Reviews on #CRISPR in cancer biology & #therapy, ROS in tumour development & progression, and cancer #proteogenomics, and Comments on esophageal cancer research in Eastern Africa and on Critical Race Theory.\nüíå https://t.co/vQwHFJhpwv@natrescancer pic.twitter.com/6kYgjRYhdT\n‚Äî NatureReviewsCancer (@NatureRevCancer) April 28, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1519678964364623872",
          "publishedOn": "2022-04-28T14:04:34.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: Our May issue, out NOW! With Reviews on #CRISPR in cancer biology & #therapy, ROS in tumour development & progression, and cancer #proteogenomics, and Comments on esophageal cancer research in Eastern Africa and on Critical Race Theory.üíå",
          "imageUrl": null
        },
        {
          "id": "fdf224ea293cdf039086d16e5699a59a",
          "author": "@tmurraystewart",
          "description": "Our latest publication on #polyamines is online!@HopkinsMedicine https://t.co/ehRGgN1w9R\n‚Äî Tracy Murray Stewart (@tmurraystewart) April 27, 2022",
          "link": "https://twitter.com/tmurraystewart/status/1519413460978704384",
          "publishedOn": "2022-04-27T20:29:33.000Z",
          "wordCount": 196,
          "title": "@tmurraystewart: Our latest publication on #polyamines is online!@HopkinsMedicine",
          "imageUrl": null
        },
        {
          "id": "4f43226ec4dc8e531ff6e64a9c5ab8e6",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Polyamines in cancer: integrating organismal metabolism and antitumour immunity https://t.co/YCJX1hRQLO pic.twitter.com/zRUCRNXyxH\n‚Äî NatureReviewsCancer (@NatureRevCancer) April 27, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1519381375874265088",
          "publishedOn": "2022-04-27T18:22:03.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Polyamines in cancer: integrating organismal metabolism and antitumour immunity",
          "imageUrl": null
        },
        {
          "id": "a44ed79b9f76aad377b9272fb392f553",
          "author": "@NatureRevCancer",
          "description": "NEW #ResearchHighlight! Lv, Liu, Mo & co demonstrate that in pancreatic #PDAC cells, gasdermin E transports YBX1 to the nucleus, which promotes mucin expression, thereby providing tumour cells with a barrier against digestive enzymes.\nüìØ https://t.co/JTUhX0DHQ1@natrescancer pic.twitter.com/2PdCmsDu2p\n‚Äî NatureReviewsCancer (@NatureRevCancer) April 27, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1519317944995569664",
          "publishedOn": "2022-04-27T14:10:00.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW #ResearchHighlight! Lv, Liu, Mo & co demonstrate that in pancreatic #PDAC cells, gasdermin E transports YBX1 to the nucleus, which promotes mucin expression, thereby providing tumour cells with a barrier against digestive enzymes.üìØ",
          "imageUrl": null
        },
        {
          "id": "06ff7641d8f5fcc0dff91f835ac3bbc1",
          "author": "@NatureRevCancer",
          "description": "In the April issue of @NatureRevCancer | Comment, Reimagining cancer research with art, by @CancerSciArtist, Stefani Shoreibah & @tdanino\n https://t.co/GeTVCMJQsp @natrescancer\n @Columbia pic.twitter.com/ZXW6A0Fe0c\n‚Äî NatureReviewsCancer (@NatureRevCancer) April 26, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1518967636561956865",
          "publishedOn": "2022-04-26T14:58:00.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: In the April issue of @NatureRevCancer | Comment, Reimagining cancer research with art, by @CancerSciArtist, Stefani Shoreibah & @tdanino  @natrescancer @Columbia",
          "imageUrl": null
        },
        {
          "id": "96b2ddff4eb269cf343213c6a1b1ce95",
          "author": "@NatureRevCancer",
          "description": "NEW content online! Tracking dormant disseminated tumour cells https://t.co/kSXyWAvCxF\n‚Äî NatureReviewsCancer (@NatureRevCancer) April 25, 2022",
          "link": "https://twitter.com/NatureRevCancer/status/1518563607440621569",
          "publishedOn": "2022-04-25T12:12:32.000Z",
          "wordCount": 196,
          "title": "@NatureRevCancer: NEW content online! Tracking dormant disseminated tumour cells",
          "imageUrl": null
        }
      ]
    },
    {
      "title": "Clonal Hematopoiesis",
      "feedUrl": "https://pubmed.ncbi.nlm.nih.gov/rss/search/1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl/?limit=15&utm_campaign=pubmed-2&fc=20220608003622",
      "siteUrl": "https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&utm_medium=rss&ff=20230405205549&utm_source=axios&fc=20220608003622&v=2.17.9.post6+86293ac&utm_campaign=pubmed-2",
      "articles": [
        {
          "id": "pubmed:37018661",
          "author": "Fernando Anjos-Afonso",
          "description": "The ability to isolate and characterize different HSPC (hematopoietic stem/progenitor cell) populations opens avenues to understand how hematopoiesis is regulated during development, homeostasis and regeneration, as well as in age-related conditions such as clonal hematopoiesis and leukemogenesis. Significant progress has been made in the past few decades in determining the composition of the cell types that exist in this system, but the most significant advances have come from mouse studies....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37018661/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-05T10:00:00.000Z",
          "wordCount": 1077,
          "title": "Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37009705",
          "author": "Grace Collord",
          "description": "Hagiwara and colleagues investigated the effects of childhood cancer treatment on the clonal composition of blood. Their findings provide strong evidence that treatment promotes clonal outgrowths (clonal hematopoiesis) in childhood cancer survivors. See related article by Hagiwara et al., p. 844 (4).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37009705/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1411,
          "title": "Childhood Cancer Treatment and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37007111",
          "author": "Moqin Jiang",
          "description": "Myelodysplastic syndromes (MDS) are clonal hematologic malignancies characterized by ineffective hematopoiesis and dysplasia of the myeloid cell lineage and are characterized by peripheral blood cytopenia and an increased risk of transformation to acute myeloid leukemia (AML). Approximately half of the patients with MDS have somatic mutations in the spliceosome gene. Splicing Factor 3B Subunit 1A (SF3B1), the most frequently occurring splicing factor mutation in MDS is significantly associated...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37007111/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1871,
          "title": "SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37009705",
          "author": "Grace Collord",
          "description": "Hagiwara and colleagues investigated the effects of childhood cancer treatment on the clonal composition of blood. Their findings provide strong evidence that treatment promotes clonal outgrowths (clonal hematopoiesis) in childhood cancer survivors. See related article by Hagiwara et al., p. 844 (4).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37009705/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1402,
          "title": "Childhood Cancer Treatment and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37007111",
          "author": "Moqin Jiang",
          "description": "Myelodysplastic syndromes (MDS) are clonal hematologic malignancies characterized by ineffective hematopoiesis and dysplasia of the myeloid cell lineage and are characterized by peripheral blood cytopenia and an increased risk of transformation to acute myeloid leukemia (AML). Approximately half of the patients with MDS have somatic mutations in the spliceosome gene. Splicing Factor 3B Subunit 1A (SF3B1), the most frequently occurring splicing factor mutation in MDS is significantly associated...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37007111/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1871,
          "title": "SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37009705",
          "author": "Grace Collord",
          "description": "Hagiwara and colleagues investigated the effects of childhood cancer treatment on the clonal composition of blood. Their findings provide strong evidence that treatment promotes clonal outgrowths (clonal hematopoiesis) in childhood cancer survivors. See related article by Hagiwara et al., p. 844 (4).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37009705/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1089,
          "title": "Childhood Cancer Treatment and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37007111",
          "author": "Moqin Jiang",
          "description": "Myelodysplastic syndromes (MDS) are clonal hematologic malignancies characterized by ineffective hematopoiesis and dysplasia of the myeloid cell lineage and are characterized by peripheral blood cytopenia and an increased risk of transformation to acute myeloid leukemia (AML). Approximately half of the patients with MDS have somatic mutations in the spliceosome gene. Splicing Factor 3B Subunit 1A (SF3B1), the most frequently occurring splicing factor mutation in MDS is significantly associated...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37007111/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1436,
          "title": "SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37003397",
          "author": "Ugo Chianese",
          "description": "Acute myeloid leukemia (AML) is a heterogeneous disease with a genetic, epigenetic, and transcriptional etiology mainly presenting somatic and germline abnormalities. AML incidence rises with age but can also occur during childhood. Pediatric AML (pAML) accounts for 15-20% of all pediatric leukemias and differs considerably from adult AML. Next-generation sequencing technologies have enabled the research community to \"paint\" the genomic and epigenomic landscape in order to identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37003397/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-01T10:00:00.000Z",
          "wordCount": 1576,
          "title": "Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37003397",
          "author": "Ugo Chianese",
          "description": "Acute myeloid leukemia (AML) is a heterogeneous disease with a genetic, epigenetic, and transcriptional etiology mainly presenting somatic and germline abnormalities. AML incidence rises with age but can also occur during childhood. Pediatric AML (pAML) accounts for 15-20% of all pediatric leukemias and differs considerably from adult AML. Next-generation sequencing technologies have enabled the research community to \"paint\" the genomic and epigenomic landscape in order to identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37003397/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-01T10:00:00.000Z",
          "wordCount": 1833,
          "title": "Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37003397",
          "author": "Ugo Chianese",
          "description": "Acute myeloid leukemia (AML) is a heterogeneous disease with a genetic, epigenetic, and transcriptional etiology mainly presenting somatic and germline abnormalities. AML incidence rises with age but can also occur during childhood. Pediatric AML (pAML) accounts for 15-20% of all pediatric leukemias and differs considerably from adult AML. Next-generation sequencing technologies have enabled the research community to \"paint\" the genomic and epigenomic landscape in order to identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37003397/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-01T10:00:00.000Z",
          "wordCount": 1833,
          "title": "Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37003397",
          "author": "Ugo Chianese",
          "description": "Acute myeloid leukemia (AML) is a heterogeneous disease with a genetic, epigenetic, and transcriptional etiology mainly presenting somatic and germline abnormalities. AML incidence rises with age but can also occur during childhood. Pediatric AML (pAML) accounts for 15-20% of all pediatric leukemias and differs considerably from adult AML. Next-generation sequencing technologies have enabled the research community to \"paint\" the genomic and epigenomic landscape in order to identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37003397/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-01T10:00:00.000Z",
          "wordCount": 1576,
          "title": "Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990546",
          "author": "Sandro Ninni",
          "description": "CONCLUSIONS: HSM is frequent in candidates for AVR, is associated with an enrichment of proinflammatory cardiac monocyte-derived macrophages, and predisposes to a higher incidence of POAF. HSM assessment may be useful in the personalized management of patients in the perioperative period. (Post-Operative Myocardial Incident & Atrial Fibrillation [POMI-AF]; NCT03376165).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990546/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2055,
          "title": "Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1423,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36988570",
          "author": "Anastasia Leshchyk",
          "description": "Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3642 subjects with familial longevity and 920 spousal controls from the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36988570/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1519,
          "title": "Mosaic chromosomal alterations and human longevity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36983964",
          "author": "CƒÉtƒÉlina Roxana Ferea",
          "description": "Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36983964/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1948,
          "title": "Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1973,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36980287",
          "author": "Sophie Combaluzier",
          "description": "Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36980287/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2117,
          "title": "Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990546",
          "author": "Sandro Ninni",
          "description": "CONCLUSIONS: HSM is frequent in candidates for AVR, is associated with an enrichment of proinflammatory cardiac monocyte-derived macrophages, and predisposes to a higher incidence of POAF. HSM assessment may be useful in the personalized management of patients in the perioperative period. (Post-Operative Myocardial Incident & Atrial Fibrillation [POMI-AF]; NCT03376165).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990546/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2294,
          "title": "Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1423,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36988570",
          "author": "Anastasia Leshchyk",
          "description": "Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3642 subjects with familial longevity and 920 spousal controls from the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36988570/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1856,
          "title": "Mosaic chromosomal alterations and human longevity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36983964",
          "author": "CƒÉtƒÉlina Roxana Ferea",
          "description": "Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36983964/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1948,
          "title": "Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1973,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36980287",
          "author": "Sophie Combaluzier",
          "description": "Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36980287/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2377,
          "title": "Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990546",
          "author": "Sandro Ninni",
          "description": "CONCLUSIONS: HSM is frequent in candidates for AVR, is associated with an enrichment of proinflammatory cardiac monocyte-derived macrophages, and predisposes to a higher incidence of POAF. HSM assessment may be useful in the personalized management of patients in the perioperative period. (Post-Operative Myocardial Incident & Atrial Fibrillation [POMI-AF]; NCT03376165).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990546/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2294,
          "title": "Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1423,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36988570",
          "author": "Anastasia Leshchyk",
          "description": "Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3642 subjects with familial longevity and 920 spousal controls from the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36988570/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1856,
          "title": "Mosaic chromosomal alterations and human longevity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36983964",
          "author": "CƒÉtƒÉlina Roxana Ferea",
          "description": "Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36983964/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1948,
          "title": "Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1973,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36980287",
          "author": "Sophie Combaluzier",
          "description": "Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36980287/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2377,
          "title": "Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990546",
          "author": "Sandro Ninni",
          "description": "CONCLUSIONS: HSM is frequent in candidates for AVR, is associated with an enrichment of proinflammatory cardiac monocyte-derived macrophages, and predisposes to a higher incidence of POAF. HSM assessment may be useful in the personalized management of patients in the perioperative period. (Post-Operative Myocardial Incident & Atrial Fibrillation [POMI-AF]; NCT03376165).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990546/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2275,
          "title": "Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1423,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36988570",
          "author": "Anastasia Leshchyk",
          "description": "Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3642 subjects with familial longevity and 920 spousal controls from the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36988570/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1856,
          "title": "Mosaic chromosomal alterations and human longevity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36983964",
          "author": "CƒÉtƒÉlina Roxana Ferea",
          "description": "Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36983964/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1948,
          "title": "Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1973,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36980287",
          "author": "Sophie Combaluzier",
          "description": "Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36980287/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2377,
          "title": "Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990546",
          "author": "Sandro Ninni",
          "description": "CONCLUSIONS: HSM is frequent in candidates for AVR, is associated with an enrichment of proinflammatory cardiac monocyte-derived macrophages, and predisposes to a higher incidence of POAF. HSM assessment may be useful in the personalized management of patients in the perioperative period. (Post-Operative Myocardial Incident & Atrial Fibrillation [POMI-AF]; NCT03376165).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990546/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2271,
          "title": "Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1419,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36988570",
          "author": "Anastasia Leshchyk",
          "description": "Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3642 subjects with familial longevity and 920 spousal controls from the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36988570/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1856,
          "title": "Mosaic chromosomal alterations and human longevity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36983964",
          "author": "CƒÉtƒÉlina Roxana Ferea",
          "description": "Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36983964/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1945,
          "title": "Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1970,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36980287",
          "author": "Sophie Combaluzier",
          "description": "Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36980287/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2377,
          "title": "Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990546",
          "author": "Sandro Ninni",
          "description": "CONCLUSIONS: HSM is frequent in candidates for AVR, is associated with an enrichment of proinflammatory cardiac monocyte-derived macrophages, and predisposes to a higher incidence of POAF. HSM assessment may be useful in the personalized management of patients in the perioperative period. (Post-Operative Myocardial Incident & Atrial Fibrillation [POMI-AF]; NCT03376165).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990546/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2274,
          "title": "Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1436,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1645,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36988570",
          "author": "Anastasia Leshchyk",
          "description": "Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3642 subjects with familial longevity and 920 spousal controls from the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36988570/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1856,
          "title": "Mosaic chromosomal alterations and human longevity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36983964",
          "author": "CƒÉtƒÉlina Roxana Ferea",
          "description": "Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36983964/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1757,
          "title": "Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1640,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36980287",
          "author": "Sophie Combaluzier",
          "description": "Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36980287/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2377,
          "title": "Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990546",
          "author": "Sandro Ninni",
          "description": "CONCLUSIONS: HSM is frequent in candidates for AVR, is associated with an enrichment of proinflammatory cardiac monocyte-derived macrophages, and predisposes to a higher incidence of POAF. HSM assessment may be useful in the personalized management of patients in the perioperative period. (Post-Operative Myocardial Incident & Atrial Fibrillation [POMI-AF]; NCT03376165).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990546/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1888,
          "title": "Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1071,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1216,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36988570",
          "author": "Anastasia Leshchyk",
          "description": "Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3642 subjects with familial longevity and 920 spousal controls from the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36988570/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1494,
          "title": "Mosaic chromosomal alterations and human longevity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36983964",
          "author": "CƒÉtƒÉlina Roxana Ferea",
          "description": "Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36983964/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1748,
          "title": "Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1670,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36980287",
          "author": "Sophie Combaluzier",
          "description": "Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36980287/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2308,
          "title": "Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1216,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36988570",
          "author": "Anastasia Leshchyk",
          "description": "Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3642 subjects with familial longevity and 920 spousal controls from the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36988570/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1477,
          "title": "Mosaic chromosomal alterations and human longevity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36983964",
          "author": "CƒÉtƒÉlina Roxana Ferea",
          "description": "Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36983964/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1413,
          "title": "Sweet Syndrome Associated with Myelodysplastic Syndrome-A Review of a Multidisciplinary Approach",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1263,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36980287",
          "author": "Sophie Combaluzier",
          "description": "Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN, BCR::ABL1-positive (Chronic Myeloid Leukemia) and BCR::ABL1-negative (Polycythemia Vera, Essential Thrombocytosis, Primary Myelofibrosis) are distinguished. For many years, cytomorphologic and histologic features were the only proof of MPN and attempted to distinguish the different entities of the subgroup...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36980287/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1324,
          "title": "Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1412,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1412,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1412,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1412,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1412,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1412,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1412,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1155,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36976266",
          "author": "Soichi Sano",
          "description": "We present a brief introduction of loss of Y chromosome (LOY) in blood, and describe the known risk factors for this condition. We then overview the associations between LOY and age-related disease traits. Finally, we discuss murine models and potential mechanisms by which LOY contributes to disease.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36976266/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1124,
          "title": "Mosaic Loss of Y Chromosome in White Blood Cells: Its Impact on Men's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1840,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2582,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36951061",
          "author": "Nadia Akhiyat",
          "description": "CONCLUSIONS: In humans, we observe patients with CMD are more likely to have CHIP, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36951061/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36949957",
          "author": "Seyedeh M Zekavat",
          "description": "Somatic mutations in blood indicative of clonal hematopoiesis of indeterminate potential (CHIP) are associated with an increased risk of hematologic malignancy, coronary artery disease, and all-cause mortality. Here we analyze the relation between CHIP status and incident peripheral artery disease (PAD) and atherosclerosis, using whole-exome sequencing and clinical data from the UK Biobank and Mass General Brigham Biobank. CHIP associated with incident PAD and atherosclerotic disease across...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36949957/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2257,
          "title": "<em>TP53-</em>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1412,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1215,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36947811",
          "author": "Helong Gary Zhao",
          "description": "Chronic or recurrent episodes of acute inflammation cause attrition of normal hematopoietic stem cells (HSCs) that can lead to hematopoietic failure, but they drive progression in myeloid malignancies and their precursor clonal hematopoiesis (CH). Mechanistic parallels exist between hematopoiesis in chronic inflammation and the continuously increased proliferation of myeloid malignancies, particularly myeloproliferative neoplasms (MPNs). The ability to enter dormancy, a state of deep quiescence...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36947811/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1178,
          "title": "ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1734,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1734,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1734,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1570,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1734,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1570,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1734,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1570,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1734,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1570,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1734,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1456,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1728,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1441,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1728,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1456,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1728,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1441,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1728,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1456,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1728,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1456,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1725,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1441,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1725,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1441,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1725,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1437,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939259",
          "author": "Yasmeen Choudhri",
          "description": "CONCLUSIONS: The current literature supports the hypothesis that host genetic factors affect vulnerability to severe COVID-19. Further research is required to confirm the full scope of relevant variants and the causal mechanisms underlying these associations. Clinical approaches, which consider the genetic basis of interindividual variability in COVID-19 and potentially other causes of critical illness, could optimize hospital resource allocation, predict responsiveness to treatment, identify...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939259/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1391,
          "title": "COVID-19 and the Genetics of Inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36938794",
          "author": "Abhishek A Mangaonkar",
          "description": "CONDITION OVERVIEW: Clonal hematopoiesis (CH) refers to age-associated expansion of somatic variants in hematopoietic stem and progenitor cells (HSPC).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36938794/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1192,
          "title": "Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3638,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3615,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3615,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2034,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36934059",
          "author": "Jan Philipp Bewersdorf",
          "description": "Biological events that contribute to the pathogenesis of myelodysplastic syndromes/neoplasms (MDS) are becoming increasingly characterized and are being translated into rationally designed therapeutic strategies. Herein, we provide updates from the first International Workshop on MDS (iwMDS) of the International Consortium for MDS (icMDS) detailing recent advances in understanding the genetic landscape of MDS, including germline predisposition, epigenetic and immune dysregulation, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36934059/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 3410,
          "title": "Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36933558",
          "author": "Rebecca Truty",
          "description": "DNA variants that arise after conception can show mosaicism, varying in presence and extent among tissues. Mosaic variants have been reported in Mendelian diseases, but further investigation is necessary to broadly understand their incidence, transmission, and clinical impact. A mosaic pathogenic variant in a disease-related gene may cause an atypical phenotype in terms of severity, clinical features, or timing of disease onset. Using high-depth sequencing, we studied results from one million...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36933558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1723,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932691",
          "author": "Silvia Mas-Peiro",
          "description": "CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFŒ≤ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932691/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1377,
          "title": "Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1614,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1614,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1614,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1614,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1609,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1606,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1606,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1606,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1606,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1464,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1416,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1556,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1606,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1710,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1265,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1327,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1421,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1676,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36930802",
          "author": "Marie-France Gagnon",
          "description": "Blood cell production is complex, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH) and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged 55 to 101 years. We...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36930802/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1265,
          "title": "Interplay Between Hereditary and Acquired Factors Determine Neutrophil Counts in Aging Individuals",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36929134",
          "author": "Michihiro Kobayashi",
          "description": "It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific immune cells. This layering of immune system development is now supported by recent studies showing the presence of fetal-derived immune cells that function in adults. It has been shown that various immune cells arise at different embryonic ages via multiple waves of hematopoiesis...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36929134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1327,
          "title": "Multiple waves of fetal-derived immune cells constitute adult immune system",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36928826",
          "author": "Inderpreet Singh",
          "description": "PURPOSE OF REVIEW: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36928826/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1421,
          "title": "Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36927626",
          "author": "Shu-Hong Lin",
          "description": "CONCLUSIONS: We found limited evidence for a relationship between HIV infection and mCAs. Although mCAs were not significantly associated with NHL, mCAs detected in several NHL cases indicate a need for further investigation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36927626/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-17T10:00:00.000Z",
          "wordCount": 1382,
          "title": "Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1778,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36924240",
          "author": "Valentin Clichet",
          "description": "The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular arguments. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features are non-contributory, but remains underestimated mostly due to a lack of standardization of cytometers. We present here an innovative model integrating artificial intelligence (AI) with MFC to improve the diagnosis and the classification of MDS. We develop a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36924240/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1728,
          "title": "Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1624,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1624,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1624,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1625,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1625,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1625,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1625,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36918531",
          "author": "Hengwei Zhang",
          "description": "Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36918531/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 4022,
          "title": "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1625,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36918531",
          "author": "Hengwei Zhang",
          "description": "Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36918531/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 4022,
          "title": "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1321,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36918531",
          "author": "Hengwei Zhang",
          "description": "Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36918531/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 4022,
          "title": "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1625,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1997,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36918531",
          "author": "Hengwei Zhang",
          "description": "Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36918531/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 4022,
          "title": "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1625,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1986,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36918531",
          "author": "Hengwei Zhang",
          "description": "Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36918531/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 4011,
          "title": "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1625,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1801,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36918531",
          "author": "Hengwei Zhang",
          "description": "Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36918531/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 2065,
          "title": "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921731",
          "author": "Cong Wang",
          "description": "Iron overload (IOL) is a common condition in patients with hematological malignancies(HMs) undergoing hematopoietic stem cell transplantation (HSCT). Pathophysiologically, IOL results in iron-induced toxicity in HSCT by producing reactive oxygen species (ROS), which leads to detrimental effects on hematopoiesis, clonal evolution, and immunosuppression. IOL, therefore, may have a negative impact on the clinical outcomes of HSCT. For patients at a higher risk of developing IOL before HSCT, it is...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921731/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1590,
          "title": "Impact of iron overload in hematopoietic stem cell transplantation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1801,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36918531",
          "author": "Hengwei Zhang",
          "description": "Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36918531/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 2065,
          "title": "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36920637",
          "author": "Jeffrey L Jensen",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36920637/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 1506,
          "title": "Clonal Hematopoiesis and the Heart: a Toxic Relationship",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36918531",
          "author": "Hengwei Zhang",
          "description": "Prior research establishing that bone interacts in coordination with the bone marrow microenvironment (BMME) to regulate hematopoietic homeostasis was largely based on analyses of individual bone-associated cell populations. Recent advances in intravital imaging has suggested that the expansion of hematopoietic stem cells (HSCs) and acute myeloid leukemia cells is restricted to bone marrow microdomains during a distinct stage of bone remodeling. These findings indicate that dynamic bone...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36918531/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 2024,
          "title": "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1426,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1426,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1426,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1426,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1426,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1426,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1426,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1426,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36915242",
          "author": "Hyunji Kim",
          "description": "Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 ml of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plasma contains not only ctDNA of tumor origin, but also DNA from normal cells or clonal hematopoiesis. Another characteristic of ctDNA is its rapid clearance from circulation; it has a half-life of 16 minutes to 2.5 hours....",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36915242/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1391,
          "title": "Clinical Circulating Tumor DNA testing for Precision Oncology",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2183,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2183,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2183,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900363",
          "author": "David Barthelemy",
          "description": "CONCLUSIONS: The Plasma-SeqSensei‚Ñ¢ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2648,
          "title": "Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900275",
          "author": "Oriol Calvete",
          "description": "There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. However, since these risk factors are not exclusive for secondary MDSs and there are multiple overlapping scenarios, a comprehensive and definitive classification is yet to come. In addition, a sporadic MDS might arise after a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900275/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2122,
          "title": "The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2183,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900363",
          "author": "David Barthelemy",
          "description": "CONCLUSIONS: The Plasma-SeqSensei‚Ñ¢ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2648,
          "title": "Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900275",
          "author": "Oriol Calvete",
          "description": "There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. However, since these risk factors are not exclusive for secondary MDSs and there are multiple overlapping scenarios, a comprehensive and definitive classification is yet to come. In addition, a sporadic MDS might arise after a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900275/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2122,
          "title": "The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2183,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900363",
          "author": "David Barthelemy",
          "description": "CONCLUSIONS: The Plasma-SeqSensei‚Ñ¢ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2648,
          "title": "Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900275",
          "author": "Oriol Calvete",
          "description": "There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. However, since these risk factors are not exclusive for secondary MDSs and there are multiple overlapping scenarios, a comprehensive and definitive classification is yet to come. In addition, a sporadic MDS might arise after a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900275/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2122,
          "title": "The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2183,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900363",
          "author": "David Barthelemy",
          "description": "CONCLUSIONS: The Plasma-SeqSensei‚Ñ¢ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2648,
          "title": "Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900275",
          "author": "Oriol Calvete",
          "description": "There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. However, since these risk factors are not exclusive for secondary MDSs and there are multiple overlapping scenarios, a comprehensive and definitive classification is yet to come. In addition, a sporadic MDS might arise after a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900275/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2122,
          "title": "The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2183,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900363",
          "author": "David Barthelemy",
          "description": "CONCLUSIONS: The Plasma-SeqSensei‚Ñ¢ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2648,
          "title": "Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900275",
          "author": "Oriol Calvete",
          "description": "There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. However, since these risk factors are not exclusive for secondary MDSs and there are multiple overlapping scenarios, a comprehensive and definitive classification is yet to come. In addition, a sporadic MDS might arise after a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900275/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2122,
          "title": "The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2177,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900363",
          "author": "David Barthelemy",
          "description": "CONCLUSIONS: The Plasma-SeqSensei‚Ñ¢ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2648,
          "title": "Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900275",
          "author": "Oriol Calvete",
          "description": "There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. However, since these risk factors are not exclusive for secondary MDSs and there are multiple overlapping scenarios, a comprehensive and definitive classification is yet to come. In addition, a sporadic MDS might arise after a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900275/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2122,
          "title": "The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2009,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1547,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900363",
          "author": "David Barthelemy",
          "description": "CONCLUSIONS: The Plasma-SeqSensei‚Ñ¢ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2230,
          "title": "Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900275",
          "author": "Oriol Calvete",
          "description": "There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. However, since these risk factors are not exclusive for secondary MDSs and there are multiple overlapping scenarios, a comprehensive and definitive classification is yet to come. In addition, a sporadic MDS might arise after a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900275/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1426,
          "title": "The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1474,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36902450",
          "author": "Phaedon D Zavras",
          "description": "Myelodysplastic syndrome (MDS) is a clonal hematopoietic neoplasm characterized by bone marrow dysplasia, failure of hematopoiesis and variable risk of progression to acute myeloid leukemia (AML). Recent large-scale studies have demonstrated that distinct molecular abnormalities detected at earlier stages of MDS alter disease biology and predict progression to AML. Consistently, various studies analyzing these diseases at the single-cell level have identified specific patterns of progression...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36902450/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1523,
          "title": "Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900363",
          "author": "David Barthelemy",
          "description": "CONCLUSIONS: The Plasma-SeqSensei‚Ñ¢ SOLID CANCER IVD kit resulted in de novo detection of targetable oncogenic drivers and resistance alterations, with a high sensitivity and accuracy for low and high cfDNA inputs. Thus, this assay is a sensitive, robust, and accurate test.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2206,
          "title": "Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36900275",
          "author": "Oriol Calvete",
          "description": "There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and MDS post-cytotoxic therapy (MDS-pCT) etiologies. However, since these risk factors are not exclusive for secondary MDSs and there are multiple overlapping scenarios, a comprehensive and definitive classification is yet to come. In addition, a sporadic MDS might arise after a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36900275/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1402,
          "title": "The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1450,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1447,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1447,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1447,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1447,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1447,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1447,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1415,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1176,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36891574",
          "author": "Sung-Eun Lee",
          "description": "Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fibrosis, and a propensity for leukemia transformation. The identification of driver mutations in JAK2, CALR, and MPL has contributed to a better understanding of disease pathogenesis and has led to the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36891574/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-09T11:00:00.000Z",
          "wordCount": 1152,
          "title": "Novel therapeutics for myelofibrosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36889927",
          "author": "Elisabeth Aline Goldman",
          "description": "Clonal hematopoiesis (CH), where hematopoietic stem and progenitor cell (HSPC) clones and their progeny expand in the circulating blood cell population, occurs following the acquisition of somatic driver mutations. Individuals diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) carry somatic mutations in hematological malignancy-associated driver genes, historically at or above a variant allele frequency of 2%, but do not exhibit abnormal blood cell counts or any other symptoms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36889927/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230317205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-08T11:00:00.000Z",
          "wordCount": 1630,
          "title": "Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36889927",
          "author": "Elisabeth Aline Goldman",
          "description": "Clonal hematopoiesis (CH), where hematopoietic stem and progenitor cell (HSPC) clones and their progeny expand in the circulating blood cell population, occurs following the acquisition of somatic driver mutations. Individuals diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) carry somatic mutations in hematological malignancy-associated driver genes, historically at or above a variant allele frequency of 2%, but do not exhibit abnormal blood cell counts or any other symptoms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36889927/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-08T11:00:00.000Z",
          "wordCount": 1630,
          "title": "Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36889927",
          "author": "Elisabeth Aline Goldman",
          "description": "Clonal hematopoiesis (CH), where hematopoietic stem and progenitor cell (HSPC) clones and their progeny expand in the circulating blood cell population, occurs following the acquisition of somatic driver mutations. Individuals diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) carry somatic mutations in hematological malignancy-associated driver genes, historically at or above a variant allele frequency of 2%, but do not exhibit abnormal blood cell counts or any other symptoms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36889927/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-08T11:00:00.000Z",
          "wordCount": 1630,
          "title": "Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36889927",
          "author": "Elisabeth Aline Goldman",
          "description": "Clonal hematopoiesis (CH), where hematopoietic stem and progenitor cell (HSPC) clones and their progeny expand in the circulating blood cell population, occurs following the acquisition of somatic driver mutations. Individuals diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) carry somatic mutations in hematological malignancy-associated driver genes, historically at or above a variant allele frequency of 2%, but do not exhibit abnormal blood cell counts or any other symptoms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36889927/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-08T11:00:00.000Z",
          "wordCount": 1630,
          "title": "Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36889927",
          "author": "Elisabeth Aline Goldman",
          "description": "Clonal hematopoiesis (CH), where hematopoietic stem and progenitor cell (HSPC) clones and their progeny expand in the circulating blood cell population, occurs following the acquisition of somatic driver mutations. Individuals diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) carry somatic mutations in hematological malignancy-associated driver genes, historically at or above a variant allele frequency of 2%, but do not exhibit abnormal blood cell counts or any other symptoms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36889927/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-08T11:00:00.000Z",
          "wordCount": 1630,
          "title": "Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36889927",
          "author": "Elisabeth Aline Goldman",
          "description": "Clonal hematopoiesis (CH), where hematopoietic stem and progenitor cell (HSPC) clones and their progeny expand in the circulating blood cell population, occurs following the acquisition of somatic driver mutations. Individuals diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) carry somatic mutations in hematological malignancy-associated driver genes, historically at or above a variant allele frequency of 2%, but do not exhibit abnormal blood cell counts or any other symptoms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36889927/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-08T11:00:00.000Z",
          "wordCount": 1630,
          "title": "Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36889927",
          "author": "Elisabeth Aline Goldman",
          "description": "Clonal hematopoiesis (CH), where hematopoietic stem and progenitor cell (HSPC) clones and their progeny expand in the circulating blood cell population, occurs following the acquisition of somatic driver mutations. Individuals diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) carry somatic mutations in hematological malignancy-associated driver genes, historically at or above a variant allele frequency of 2%, but do not exhibit abnormal blood cell counts or any other symptoms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36889927/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-08T11:00:00.000Z",
          "wordCount": 1386,
          "title": "Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36889927",
          "author": "Elisabeth Aline Goldman",
          "description": "Clonal hematopoiesis (CH), where hematopoietic stem and progenitor cell (HSPC) clones and their progeny expand in the circulating blood cell population, occurs following the acquisition of somatic driver mutations. Individuals diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) carry somatic mutations in hematological malignancy-associated driver genes, historically at or above a variant allele frequency of 2%, but do not exhibit abnormal blood cell counts or any other symptoms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36889927/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-08T11:00:00.000Z",
          "wordCount": 1386,
          "title": "Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2170,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2170,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2170,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2170,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2170,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2170,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 1875,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 1875,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 1819,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36875910",
          "author": "Ragani Velusamy",
          "description": "Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in cancer survivors. This review identifies features that could help guide decisions about the benefit of screening to assess the risk or presence of subclinical CAD. Screening may be appropriate in selected survivors based on risk factors and inflammatory burden. In cancer survivors who have undergone genetic testing, polygenic risk scores and clonal hematopoiesis markers may become useful CAD risk prediction...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36875910/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 1819,
          "title": "Screening for Coronary Artery Disease in¬†Cancer Survivors: <em>JACC: CardioOncology</em> State-of-the-Art¬†Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2329,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2095,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2329,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2082,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2329,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2082,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2329,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2095,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2329,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2082,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2367,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2054,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2069,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1793,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2069,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1793,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2063,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1793,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36864496",
          "author": "Jihye Park",
          "description": "CONCLUSIONS: Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36864496/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 2063,
          "title": "Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh√ßet's disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1793,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1634,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1630,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1630,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36862966",
          "author": "Mihaela Aldea",
          "description": "CONCLUSION: The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36862966/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1606,
          "title": "Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1825,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1825,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1825,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1825,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1825,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1825,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1455,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1455,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1455,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1455,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1455,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1420,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1420,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1420,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1420,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36853803",
          "author": "Laneshia K Tague",
          "description": "CONCLUSION: In patients with severe lung disease requiring lung transplantation, CH due to somatic variants in PPM1D, TP53 or ATM is highly prevalent and associated with post-transplant outcomes including cytomegalovirus activation and mycophenolate intolerance.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36853803/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1396,
          "title": "Clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation is increased",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230315210334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2132,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2132,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1902,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2132,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1902,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2132,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1902,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2132,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1902,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2126,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1472,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2122,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1917,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2100,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1448,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2012,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1800,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2096,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841022",
          "author": "Carmelo Gurnari",
          "description": "Clonal hematopoiesis (CH) is a result of the selective expansion of hematopoietic stem and progenitor cells (HSPCs) carrying somatic mutations originating from a primary HSC. The advent of modern genomic technologies has helped recognizing that CH is common in elderly healthy subjects as a result of the aging bone marrow (BM). CH in healthy subjects without abnormalities in blood counts is known as CH of indeterminate potential. CH is also seen in BM failure (BMF) disorders. Whether CH alarms...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841022/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1231,
          "title": "From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2012,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1755,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2051,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835370",
          "author": "Petra B√ºttner",
          "description": "Clonal hematopoiesis (CH)-associated mutations increase the risk of atherosclerotic cardiovascular diseases. However, it is unclear whether the mutations detected in circulating blood cells can also be detected in tissues associated with atherosclerosis, where they could affect physiology locally. To address this, the presence of CH mutations in peripheral blood, atherosclerotic lesions and associated tissues was assessed in a pilot study of 31 consecutive patients with peripheral vascular...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835370/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1726,
          "title": "Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831198",
          "author": "Bryanna Reinhardt",
          "description": "Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), macrophage activation syndrome (MAS), and prolonged cytopenias-a reduction in the number of mature blood cells...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831198/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1431,
          "title": "Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36830925",
          "author": "Mihnea-Alexandru GƒÉman",
          "description": "The impact of primary arterial hypertension (HTN) in myeloproliferative neoplasms (MPNs) remains unclear, with scant literature available, mostly focusing on cardiovascular risk factors as a singular entity or on organ-specific HTN. Furthermore, available studies reporting findings on drug-induced HTN in MPNs report varying and contradictory findings. In consideration of the above, this study set out to systematically review the available literature and shed light on the occurrence of HTN in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36830925/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1655,
          "title": "Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1678,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1678,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1644,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1681,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1681,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1681,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1681,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1681,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1681,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1681,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1671,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1671,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1666,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1543,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1509,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36828612",
          "author": "Eugenia Gianos",
          "description": "In this JCL Roundtable, we bring together three experts to discuss women's cardiovascular health throughout the lifespan, viewed from the standpoint of clinical lipidology. Overall, heart disease leads to one out of every 3 deaths of American women, but unfortunately patient awareness of cardiovascular risk actually has declined since 2009. Younger women are not exempt, since their risk can be increased by smoking, birth control, adverse lifestyle and diet, and genetic disorders. Age at menarche...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36828612/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1509,
          "title": "JCL Roundtable: Lipidology and Women's Health",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1756,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1756,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1734,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1738,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1738,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1738,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1738,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1738,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1738,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1738,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1738,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1560,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1867,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1727,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1559,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1866,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1593,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1559,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1593,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1524,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1833,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822179",
          "author": "Zhenzhen Li",
          "description": "RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822179/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1593,
          "title": "RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36822077",
          "author": "Francesco Tarantini",
          "description": "Life expectation of chronic myeloid leukemia patients in the tyrosine kinase inhibitors era is almost equal to that of healthy subjects. On the other hand, their long-term management must take into account a higher risk of adverse events, at least partly related to the treatment. Various studies reported a higher incidence of cardiovascular events in these patients. Clonal hematopoiesis is broadly considered a major independent risk factor for cardiovascular events. Of note, the underlying...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36822077/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1524,
          "title": "Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1833,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36815747",
          "author": "Vasiliki Papadopoulou",
          "description": "CONCLUSIONS: IDH1/2 mutations are most frequently accompanied by DNMT3A, SRSF2 and NPM1 mutations. NPM1-IDH1/2 mutated AML has a mature phenotype possibly amenable to differentiation therapies. IDH1/2 and SRSF2 mutations probably arise at the same developmental stage of the disease, as their allele burdens covariate. IDH1/2 mutation represents CHIP in a substantial proportion of cases and is therefore no reliable residual disease marker. The preferential presence of IDH1/2 mutations among...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36815747/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-23T11:00:00.000Z",
          "wordCount": 1242,
          "title": "Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1898,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1898,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230306200849&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1898,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1898,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1898,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1898,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1478,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1898,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1475,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1895,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1475,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1896,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1895,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1474,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1891,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1863,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1399,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1465,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1863,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1401,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1465,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1894,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1401,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1465,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1894,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1401,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1285,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1543,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1592,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1075,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36811645",
          "author": "Soichi Sano",
          "description": "PURPOSE OF REVIEW: Somatic mutations, described as noninherited changes in DNA that arise and are passed on to descendant cells, are well known to cause cancers; however, it is increasingly appreciated that the propagation of somatic mutations within a tissue may have a role in causing nonneoplastic disorders and abnormalities in elderly individuals. The nonmalignant clonal expansion of somatic mutations in the hematopoietic system is termed clonal hematopoiesis. This review will briefly discuss...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36811645/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1244,
          "title": "Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36808603",
          "author": "Ariel H Polizio",
          "description": "PURPOSE OF REVIEW: Clonal hematopoiesis (CH) is a prevalent condition that results from the acquisition of somatic mutations in hematopoietic stem cells. When these mutations occur in \"driver\" genes, they can potentially confer fitness advantages to the cell, leading to a clonal expansion. While most clonal expansions of mutant cells are generally considered to be asymptomatic since they do not impact overall blood cell numbers, CH carriers display long-term risks of all-cause mortality and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36808603/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1477,
          "title": "Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807865",
          "author": "Woo-Jin Lee",
          "description": "CONCLUSIONS: Clonal hematopoiesis with DNMT3A mutation is quantitatively associated with a lower volume of cerebral WMH, especially in the periventricular region. CHIP with DNMT3A mutation might have a protective role in the endothelial pathomechanism of WMH.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807865/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1561,
          "title": "Clonal hematopoiesis with DNMT3A mutation is associated with lower white matter hyperintensity volume",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1037,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2041,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2041,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2041,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2041,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2041,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1752,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2038,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1752,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2037,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1751,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1746,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2037,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1751,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1746,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2037,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1751,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1746,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2037,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1751,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1746,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2037,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1751,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1746,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 2026,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1751,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1746,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1999,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1724,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1719,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1999,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1724,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1719,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1999,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1724,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1719,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1999,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1724,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1719,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1999,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1724,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1719,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1999,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1724,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1719,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789775",
          "author": "Ernst Mayerhofer",
          "description": "CONCLUSIONS: Using genetic screening for myeloid disorders in patients with stroke of predominantly undetermined etiology, we found a 3-fold higher CHIP prevalence than in the general population. We identified high-risk CHIP and previously covert myeloproliferative neoplasms as potential stroke etiologies in 4.4% and 1% of patients, respectively. Our findings demonstrate the diagnostic and therapeutic yield of genetic screening in young patients with stroke. Future studies should investigate the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789775/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1966,
          "title": "Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789433",
          "author": "Kai Yu",
          "description": "Germline RUNX1 mutations lead to familial platelet disorder with associated myeloid malignancies (FPDMM), which is characterized by thrombocytopenia and a life-long risk (35-45%) of hematological malignancies. We recently launched a longitudinal natural history study for patients with FPDMM at the NIH Clinical Center. Among 29 families with research genomic data, 28 different germline RUNX1 variants were detected. Besides missense mutations enriched in Runt homology domain and loss-of-function...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789433/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1665,
          "title": "Genomic Landscape of Patients with Germline <em>RUNX1</em> Variants and Familial Platelet Disorder with Myeloid Malignancy",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789423",
          "author": "Tae-Hoon Shin",
          "description": "Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789423/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1660,
          "title": "Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1530,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1530,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2976,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1530,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2976,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1530,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2976,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1503,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2949,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1503,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2949,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1503,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2949,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1503,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2949,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1503,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2949,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1503,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2949,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1503,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2949,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1454,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2895,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1128,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776372",
          "author": "Hiu Ting Chan",
          "description": "CONCLUSION: Longitudinal monitoring using tumor-informed ctDNA testing shows high analytical sensitivity, low probability of false-positive results due to CH mutations, and improved sensitivity in detecting recurrence which may modify the clinical management of CRC.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776372/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2895,
          "title": "Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1644,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1644,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1644,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1617,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1617,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1617,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1617,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1617,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1617,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1614,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1611,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1568,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1276,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36768584",
          "author": "Sofia Camerlo",
          "description": "Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the pathological and therapeutic level. It is frequently associated with liver cirrhosis, but it could also be provoked by myeloproliferative disorders, cancer of various gastroenterological origin, abdominal infections and thrombophilia. A portion of splanchnic vein thrombosis is still classified as idiopathic. Here, we review the mechanisms of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36768584/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1276,
          "title": "Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1430,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1642,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1430,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1642,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1430,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1642,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1615,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1615,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1615,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1615,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1615,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1615,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1615,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1615,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1594,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1594,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1594,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230210195718&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1403,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230210195718&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1594,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36754028",
          "author": "Nitya Prabhakaran",
          "description": "Erdheim-Chester disease (ECD) is a rare clonal histiocytic process that is characterized by a foamy (xanthomatous) proliferation often associated with Touton giant cells. The diagnosis is often challenging and not exclusively a histologic diagnosis, as it requires correlation with unique clinical, radiographic and recently described molecular findings. Activating mutations involving the MAPK pathway including BRAF, ARAF, N/KRAS and MEK are recurrent in the disease. However, it is increasingly...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36754028/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230209200537&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1344,
          "title": "Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230209200537&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1545,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36751942",
          "author": "Kohei Hagiwara",
          "description": "We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep-sequencing over 39 CH-related genes reveals mutations in 15% of the survivors, significantly higher than the 8.5% in 324 community controls. CH in survivors is associated with exposures to alkylating agents, radiation, and bleomycin. Therapy-related CH shows significant enrichment in STAT3, characterized as a CH-gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36751942/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230208200033&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-08T11:00:00.000Z",
          "wordCount": 1545,
          "title": "Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2324,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2324,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230219200501&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230218200425&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230210195718&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230209200537&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230208200033&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230207200158&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2297,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36741006",
          "author": "Eugenia Accorsi Buttini",
          "description": "CONCLUSION: We describe a case of HR-MDS, with deletion of chromosome 7 and acquisition of RUNX1 mutation, developing after CAR T-cell therapy in a patient with clonal hematopoiesis (CH). Previous chemotherapy favored MDS onset; however, we could not exclude the fact that the impairment of immunosurveillance related to either lymphodepletion or CAR T-cell infusion may play a role in MDS development. Thus, we designed a multicenter prospective study (ClonHema-CAR-T-Study) to investigate if...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36741006/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1TSNW3JJ2DCkNHmqtItKm189ayyfigsz0lfhc8yQ7h2yfXzYrl&fc=20220608003622&ff=20230206200034&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-06T11:00:00.000Z",
          "wordCount": 2231,
          "title": "High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        }
      ]
    },
    {
      "title": "#cancer#tumor#evolution#somatic",
      "feedUrl": "https://pubmed.ncbi.nlm.nih.gov/rss/search/1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs/?limit=15&utm_campaign=pubmed-2&fc=20220608010801",
      "siteUrl": "https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&utm_source=axios&ff=20230405205549&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&utm_medium=rss&v=2.17.9.post6+86293ac&utm_campaign=pubmed-2&fc=20220608010801",
      "articles": [
        {
          "id": "pubmed:37012292",
          "author": "Mario P√©rez-Jim√©nez",
          "description": "Almost all cancer types share the hallmarks of cancer and a similar tumor formation: fueled by stochastic mutations in somatic cells. In case of chronic myeloid leukemia (CML), this evolutionary process can be tracked from an asymptomatic long-lasting chronic phase to a final rapidly evolving blast phase. Somatic evolution in CML occurs in the context of healthy blood production, a hierarchical process of cell division; initiated by stem cells that self-renew and differentiate to produce mature...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37012292/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 2438,
          "title": "The structure of the hematopoietic system can explain chronic myeloid leukemia progression",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37009705",
          "author": "Grace Collord",
          "description": "Hagiwara and colleagues investigated the effects of childhood cancer treatment on the clonal composition of blood. Their findings provide strong evidence that treatment promotes clonal outgrowths (clonal hematopoiesis) in childhood cancer survivors. See related article by Hagiwara et al., p. 844 (4).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37009705/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1411,
          "title": "Childhood Cancer Treatment and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37009703",
          "author": "Alison A McBride",
          "description": "Human papillomavirus (HPV)-positive cancer cells contain virus and host DNA and exhibit marked genome instability. In this issue of Cancer Discovery, Akagi and colleagues characterize the remarkably complex landscape of virus-host DNA molecules in HPV-positive cells, providing evidence for diverse integrated and extrachromosomal virus-host hybrid DNAs with the potential to drive clonal evolution. See related article by Akagi et al., p. 910 (4).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37009703/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1239,
          "title": "HPV Integration Can Drive the Formation of Virus-Host Extrachromosomal DNA in Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37008163",
          "author": "Francesca Fioredda",
          "description": "Neutropenia, as an isolated blood cell deficiency, is a feature of a wide spectrum of acquired or congenital, benign or premalignant disorders with a predisposition to develop myelodysplastic neoplasms/acute myeloid leukemia that may arise at any age. In recent years, advances in diagnostic methodologies, particularly in the field of genomics, have revealed novel genes and mechanisms responsible for etiology and disease evolution and opened new perspectives for tailored treatment. Despite the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37008163/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 2421,
          "title": "The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37012292",
          "author": "Mario P√©rez-Jim√©nez",
          "description": "Almost all cancer types share the hallmarks of cancer and a similar tumor formation: fueled by stochastic mutations in somatic cells. In case of chronic myeloid leukemia (CML), this evolutionary process can be tracked from an asymptomatic long-lasting chronic phase to a final rapidly evolving blast phase. Somatic evolution in CML occurs in the context of healthy blood production, a hierarchical process of cell division; initiated by stem cells that self-renew and differentiate to produce mature...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37012292/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1358,
          "title": "The structure of the hematopoietic system can explain chronic myeloid leukemia progression",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37009705",
          "author": "Grace Collord",
          "description": "Hagiwara and colleagues investigated the effects of childhood cancer treatment on the clonal composition of blood. Their findings provide strong evidence that treatment promotes clonal outgrowths (clonal hematopoiesis) in childhood cancer survivors. See related article by Hagiwara et al., p. 844 (4).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37009705/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1402,
          "title": "Childhood Cancer Treatment and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37009703",
          "author": "Alison A McBride",
          "description": "Human papillomavirus (HPV)-positive cancer cells contain virus and host DNA and exhibit marked genome instability. In this issue of Cancer Discovery, Akagi and colleagues characterize the remarkably complex landscape of virus-host DNA molecules in HPV-positive cells, providing evidence for diverse integrated and extrachromosomal virus-host hybrid DNAs with the potential to drive clonal evolution. See related article by Akagi et al., p. 910 (4).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37009703/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1452,
          "title": "HPV Integration Can Drive the Formation of Virus-Host Extrachromosomal DNA in Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37008163",
          "author": "Francesca Fioredda",
          "description": "Neutropenia, as an isolated blood cell deficiency, is a feature of a wide spectrum of acquired or congenital, benign or premalignant disorders with a predisposition to develop myelodysplastic neoplasms/acute myeloid leukemia that may arise at any age. In recent years, advances in diagnostic methodologies, particularly in the field of genomics, have revealed novel genes and mechanisms responsible for etiology and disease evolution and opened new perspectives for tailored treatment. Despite the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37008163/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 2421,
          "title": "The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37009703",
          "author": "Alison A McBride",
          "description": "Human papillomavirus (HPV)-positive cancer cells contain virus and host DNA and exhibit marked genome instability. In this issue of Cancer Discovery, Akagi and colleagues characterize the remarkably complex landscape of virus-host DNA molecules in HPV-positive cells, providing evidence for diverse integrated and extrachromosomal virus-host hybrid DNAs with the potential to drive clonal evolution. See related article by Akagi et al., p. 910 (4).",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37009703/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 1116,
          "title": "HPV Integration Can Drive the Formation of Virus-Host Extrachromosomal DNA in Tumors",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37008163",
          "author": "Francesca Fioredda",
          "description": "Neutropenia, as an isolated blood cell deficiency, is a feature of a wide spectrum of acquired or congenital, benign or premalignant disorders with a predisposition to develop myelodysplastic neoplasms/acute myeloid leukemia that may arise at any age. In recent years, advances in diagnostic methodologies, particularly in the field of genomics, have revealed novel genes and mechanisms responsible for etiology and disease evolution and opened new perspectives for tailored treatment. Despite the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37008163/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-04-03T10:00:00.000Z",
          "wordCount": 2173,
          "title": "The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37002477",
          "author": "Nabih Maslah",
          "description": "Myeloproliferative neoplasms are characterized by the acquisition at the hematopoietic stem cell level of driver mutations targeting the JAK/STAT pathway. In addition, they also often exhibit additional mutations targeting various pathways such as intracellular signalling, epigenetics, mRNA splicing or transcription. The natural history of myeloproliferative neoplasms is usually marked by a chronic phase of variable duration depending on the disease subtype, which can be followed by an...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37002477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-31T10:00:00.000Z",
          "wordCount": 1740,
          "title": "Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37002477",
          "author": "Nabih Maslah",
          "description": "Myeloproliferative neoplasms are characterized by the acquisition at the hematopoietic stem cell level of driver mutations targeting the JAK/STAT pathway. In addition, they also often exhibit additional mutations targeting various pathways such as intracellular signalling, epigenetics, mRNA splicing or transcription. The natural history of myeloproliferative neoplasms is usually marked by a chronic phase of variable duration depending on the disease subtype, which can be followed by an...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37002477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-31T10:00:00.000Z",
          "wordCount": 1740,
          "title": "Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37002477",
          "author": "Nabih Maslah",
          "description": "Myeloproliferative neoplasms are characterized by the acquisition at the hematopoietic stem cell level of driver mutations targeting the JAK/STAT pathway. In addition, they also often exhibit additional mutations targeting various pathways such as intracellular signalling, epigenetics, mRNA splicing or transcription. The natural history of myeloproliferative neoplasms is usually marked by a chronic phase of variable duration depending on the disease subtype, which can be followed by an...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37002477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-31T10:00:00.000Z",
          "wordCount": 1740,
          "title": "Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37002477",
          "author": "Nabih Maslah",
          "description": "Myeloproliferative neoplasms are characterized by the acquisition at the hematopoietic stem cell level of driver mutations targeting the JAK/STAT pathway. In addition, they also often exhibit additional mutations targeting various pathways such as intracellular signalling, epigenetics, mRNA splicing or transcription. The natural history of myeloproliferative neoplasms is usually marked by a chronic phase of variable duration depending on the disease subtype, which can be followed by an...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37002477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-31T10:00:00.000Z",
          "wordCount": 1740,
          "title": "Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:37002477",
          "author": "Nabih Maslah",
          "description": "Myeloproliferative neoplasms are characterized by the acquisition at the hematopoietic stem cell level of driver mutations targeting the JAK/STAT pathway. In addition, they also often exhibit additional mutations targeting various pathways such as intracellular signalling, epigenetics, mRNA splicing or transcription. The natural history of myeloproliferative neoplasms is usually marked by a chronic phase of variable duration depending on the disease subtype, which can be followed by an...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/37002477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-31T10:00:00.000Z",
          "wordCount": 1473,
          "title": "Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36994199",
          "author": "Richa Malhotra",
          "description": "INTRODUCTION: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and facilitates targeted therapy options. In this study, we propose to validate a whole exome-based tumor molecular profiling for DNA and RNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36994199/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 2390,
          "title": "An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993558",
          "author": "Jake R Conway",
          "description": "The extent to which clinical and genomic characteristics associate with prostate cancer clonal architecture, tumor evolution, and therapeutic response remains unclear. Here, we reconstructed the clonal architecture and evolutionary trajectories of 845 prostate cancer tumors with harmonized clinical and molecular data. We observed that tumors from patients who self-reported as Black had more linear and monoclonal architectures, despite these men having higher rates of biochemical recurrence. This...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1567,
          "title": "Analysis of evolutionary dynamics and clonal architecture in prostate cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993286",
          "author": "Kathleen E Houlahan",
          "description": "Cancer represents a broad spectrum of molecularly and morphologically diverse diseases. Individuals with the same clinical diagnosis can have tumors with drastically different molecular profiles and clinical response to treatment. It remains unclear when these differences arise during disease course and why some tumors are addicted to one oncogenic pathway over another. Somatic genomic aberrations occur within the context of an individual's germline genome, which can vary across millions of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993286/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 3031,
          "title": "Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36994199",
          "author": "Richa Malhotra",
          "description": "INTRODUCTION: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and facilitates targeted therapy options. In this study, we propose to validate a whole exome-based tumor molecular profiling for DNA and RNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36994199/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 2390,
          "title": "An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993558",
          "author": "Jake R Conway",
          "description": "The extent to which clinical and genomic characteristics associate with prostate cancer clonal architecture, tumor evolution, and therapeutic response remains unclear. Here, we reconstructed the clonal architecture and evolutionary trajectories of 845 prostate cancer tumors with harmonized clinical and molecular data. We observed that tumors from patients who self-reported as Black had more linear and monoclonal architectures, despite these men having higher rates of biochemical recurrence. This...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1567,
          "title": "Analysis of evolutionary dynamics and clonal architecture in prostate cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993286",
          "author": "Kathleen E Houlahan",
          "description": "Cancer represents a broad spectrum of molecularly and morphologically diverse diseases. Individuals with the same clinical diagnosis can have tumors with drastically different molecular profiles and clinical response to treatment. It remains unclear when these differences arise during disease course and why some tumors are addicted to one oncogenic pathway over another. Somatic genomic aberrations occur within the context of an individual's germline genome, which can vary across millions of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993286/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1523,
          "title": "Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36994199",
          "author": "Richa Malhotra",
          "description": "INTRODUCTION: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and facilitates targeted therapy options. In this study, we propose to validate a whole exome-based tumor molecular profiling for DNA and RNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36994199/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 2390,
          "title": "An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993558",
          "author": "Jake R Conway",
          "description": "The extent to which clinical and genomic characteristics associate with prostate cancer clonal architecture, tumor evolution, and therapeutic response remains unclear. Here, we reconstructed the clonal architecture and evolutionary trajectories of 845 prostate cancer tumors with harmonized clinical and molecular data. We observed that tumors from patients who self-reported as Black had more linear and monoclonal architectures, despite these men having higher rates of biochemical recurrence. This...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1567,
          "title": "Analysis of evolutionary dynamics and clonal architecture in prostate cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993286",
          "author": "Kathleen E Houlahan",
          "description": "Cancer represents a broad spectrum of molecularly and morphologically diverse diseases. Individuals with the same clinical diagnosis can have tumors with drastically different molecular profiles and clinical response to treatment. It remains unclear when these differences arise during disease course and why some tumors are addicted to one oncogenic pathway over another. Somatic genomic aberrations occur within the context of an individual's germline genome, which can vary across millions of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993286/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1523,
          "title": "Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36994199",
          "author": "Richa Malhotra",
          "description": "INTRODUCTION: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and facilitates targeted therapy options. In this study, we propose to validate a whole exome-based tumor molecular profiling for DNA and RNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36994199/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 2390,
          "title": "An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993558",
          "author": "Jake R Conway",
          "description": "The extent to which clinical and genomic characteristics associate with prostate cancer clonal architecture, tumor evolution, and therapeutic response remains unclear. Here, we reconstructed the clonal architecture and evolutionary trajectories of 845 prostate cancer tumors with harmonized clinical and molecular data. We observed that tumors from patients who self-reported as Black had more linear and monoclonal architectures, despite these men having higher rates of biochemical recurrence. This...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1567,
          "title": "Analysis of evolutionary dynamics and clonal architecture in prostate cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993286",
          "author": "Kathleen E Houlahan",
          "description": "Cancer represents a broad spectrum of molecularly and morphologically diverse diseases. Individuals with the same clinical diagnosis can have tumors with drastically different molecular profiles and clinical response to treatment. It remains unclear when these differences arise during disease course and why some tumors are addicted to one oncogenic pathway over another. Somatic genomic aberrations occur within the context of an individual's germline genome, which can vary across millions of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993286/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1523,
          "title": "Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36994199",
          "author": "Richa Malhotra",
          "description": "INTRODUCTION: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and facilitates targeted therapy options. In this study, we propose to validate a whole exome-based tumor molecular profiling for DNA and RNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36994199/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 2381,
          "title": "An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993558",
          "author": "Jake R Conway",
          "description": "The extent to which clinical and genomic characteristics associate with prostate cancer clonal architecture, tumor evolution, and therapeutic response remains unclear. Here, we reconstructed the clonal architecture and evolutionary trajectories of 845 prostate cancer tumors with harmonized clinical and molecular data. We observed that tumors from patients who self-reported as Black had more linear and monoclonal architectures, despite these men having higher rates of biochemical recurrence. This...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1555,
          "title": "Analysis of evolutionary dynamics and clonal architecture in prostate cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993286",
          "author": "Kathleen E Houlahan",
          "description": "Cancer represents a broad spectrum of molecularly and morphologically diverse diseases. Individuals with the same clinical diagnosis can have tumors with drastically different molecular profiles and clinical response to treatment. It remains unclear when these differences arise during disease course and why some tumors are addicted to one oncogenic pathway over another. Somatic genomic aberrations occur within the context of an individual's germline genome, which can vary across millions of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993286/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1511,
          "title": "Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36994199",
          "author": "Richa Malhotra",
          "description": "INTRODUCTION: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and facilitates targeted therapy options. In this study, we propose to validate a whole exome-based tumor molecular profiling for DNA and RNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36994199/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 2381,
          "title": "An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993558",
          "author": "Jake R Conway",
          "description": "The extent to which clinical and genomic characteristics associate with prostate cancer clonal architecture, tumor evolution, and therapeutic response remains unclear. Here, we reconstructed the clonal architecture and evolutionary trajectories of 845 prostate cancer tumors with harmonized clinical and molecular data. We observed that tumors from patients who self-reported as Black had more linear and monoclonal architectures, despite these men having higher rates of biochemical recurrence. This...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1555,
          "title": "Analysis of evolutionary dynamics and clonal architecture in prostate cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993286",
          "author": "Kathleen E Houlahan",
          "description": "Cancer represents a broad spectrum of molecularly and morphologically diverse diseases. Individuals with the same clinical diagnosis can have tumors with drastically different molecular profiles and clinical response to treatment. It remains unclear when these differences arise during disease course and why some tumors are addicted to one oncogenic pathway over another. Somatic genomic aberrations occur within the context of an individual's germline genome, which can vary across millions of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993286/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1511,
          "title": "Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36994199",
          "author": "Richa Malhotra",
          "description": "INTRODUCTION: The concept of personalized medicine in cancer has emerged rapidly with the advancement of genome sequencing and the identification of clinically relevant variants that contribute to disease prognosis and facilitates targeted therapy options. In this study, we propose to validate a whole exome-based tumor molecular profiling for DNA and RNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36994199/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1991,
          "title": "An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993558",
          "author": "Jake R Conway",
          "description": "The extent to which clinical and genomic characteristics associate with prostate cancer clonal architecture, tumor evolution, and therapeutic response remains unclear. Here, we reconstructed the clonal architecture and evolutionary trajectories of 845 prostate cancer tumors with harmonized clinical and molecular data. We observed that tumors from patients who self-reported as Black had more linear and monoclonal architectures, despite these men having higher rates of biochemical recurrence. This...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993558/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1192,
          "title": "Analysis of evolutionary dynamics and clonal architecture in prostate cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36993286",
          "author": "Kathleen E Houlahan",
          "description": "Cancer represents a broad spectrum of molecularly and morphologically diverse diseases. Individuals with the same clinical diagnosis can have tumors with drastically different molecular profiles and clinical response to treatment. It remains unclear when these differences arise during disease course and why some tumors are addicted to one oncogenic pathway over another. Somatic genomic aberrations occur within the context of an individual's germline genome, which can vary across millions of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36993286/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-30T10:00:00.000Z",
          "wordCount": 1199,
          "title": "Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1423,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982875",
          "author": "Lili Kotmayer",
          "description": "The oral, highly selective Bcl2 inhibitor venetoclax has substantially improved the therapeutic landscape of chronic lymphocytic leukemia (CLL). Despite the remarkable response rates in patients with relapsed/refractory (R/R) disease, acquired resistance is the leading cause of treatment failure, with somatic BCL2 mutations being the predominant genetic drivers underpinning venetoclax resistance. To assess the correlation between disease progression and the most common BCL2 mutations G101V and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982875/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3287,
          "title": "Landscape of <em>BCL2</em> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1973,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982036",
          "author": "Sarah Sandmann",
          "description": "The accurate reconstruction of clonal evolution, including the identification of newly developing, highly aggressive subclones, is essential for the application of precision medicine in cancer treatment. Reconstruction, aiming for correct variant clustering and clonal evolution tree reconstruction, is commonly performed by tedious manual work. While there is a plethora of tools to automatically generate reconstruction, their reliability, especially reasons for unreliability, are not...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982036/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3358,
          "title": "Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1423,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982875",
          "author": "Lili Kotmayer",
          "description": "The oral, highly selective Bcl2 inhibitor venetoclax has substantially improved the therapeutic landscape of chronic lymphocytic leukemia (CLL). Despite the remarkable response rates in patients with relapsed/refractory (R/R) disease, acquired resistance is the leading cause of treatment failure, with somatic BCL2 mutations being the predominant genetic drivers underpinning venetoclax resistance. To assess the correlation between disease progression and the most common BCL2 mutations G101V and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982875/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3287,
          "title": "Landscape of <em>BCL2</em> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1973,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982036",
          "author": "Sarah Sandmann",
          "description": "The accurate reconstruction of clonal evolution, including the identification of newly developing, highly aggressive subclones, is essential for the application of precision medicine in cancer treatment. Reconstruction, aiming for correct variant clustering and clonal evolution tree reconstruction, is commonly performed by tedious manual work. While there is a plethora of tools to automatically generate reconstruction, their reliability, especially reasons for unreliability, are not...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982036/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3358,
          "title": "Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1423,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982875",
          "author": "Lili Kotmayer",
          "description": "The oral, highly selective Bcl2 inhibitor venetoclax has substantially improved the therapeutic landscape of chronic lymphocytic leukemia (CLL). Despite the remarkable response rates in patients with relapsed/refractory (R/R) disease, acquired resistance is the leading cause of treatment failure, with somatic BCL2 mutations being the predominant genetic drivers underpinning venetoclax resistance. To assess the correlation between disease progression and the most common BCL2 mutations G101V and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982875/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3287,
          "title": "Landscape of <em>BCL2</em> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1973,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982036",
          "author": "Sarah Sandmann",
          "description": "The accurate reconstruction of clonal evolution, including the identification of newly developing, highly aggressive subclones, is essential for the application of precision medicine in cancer treatment. Reconstruction, aiming for correct variant clustering and clonal evolution tree reconstruction, is commonly performed by tedious manual work. While there is a plethora of tools to automatically generate reconstruction, their reliability, especially reasons for unreliability, are not...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982036/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3358,
          "title": "Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1423,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982875",
          "author": "Lili Kotmayer",
          "description": "The oral, highly selective Bcl2 inhibitor venetoclax has substantially improved the therapeutic landscape of chronic lymphocytic leukemia (CLL). Despite the remarkable response rates in patients with relapsed/refractory (R/R) disease, acquired resistance is the leading cause of treatment failure, with somatic BCL2 mutations being the predominant genetic drivers underpinning venetoclax resistance. To assess the correlation between disease progression and the most common BCL2 mutations G101V and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982875/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3287,
          "title": "Landscape of <em>BCL2</em> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1973,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982036",
          "author": "Sarah Sandmann",
          "description": "The accurate reconstruction of clonal evolution, including the identification of newly developing, highly aggressive subclones, is essential for the application of precision medicine in cancer treatment. Reconstruction, aiming for correct variant clustering and clonal evolution tree reconstruction, is commonly performed by tedious manual work. While there is a plethora of tools to automatically generate reconstruction, their reliability, especially reasons for unreliability, are not...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982036/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3358,
          "title": "Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1419,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1644,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982875",
          "author": "Lili Kotmayer",
          "description": "The oral, highly selective Bcl2 inhibitor venetoclax has substantially improved the therapeutic landscape of chronic lymphocytic leukemia (CLL). Despite the remarkable response rates in patients with relapsed/refractory (R/R) disease, acquired resistance is the leading cause of treatment failure, with somatic BCL2 mutations being the predominant genetic drivers underpinning venetoclax resistance. To assess the correlation between disease progression and the most common BCL2 mutations G101V and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982875/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3274,
          "title": "Landscape of <em>BCL2</em> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1970,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982036",
          "author": "Sarah Sandmann",
          "description": "The accurate reconstruction of clonal evolution, including the identification of newly developing, highly aggressive subclones, is essential for the application of precision medicine in cancer treatment. Reconstruction, aiming for correct variant clustering and clonal evolution tree reconstruction, is commonly performed by tedious manual work. While there is a plethora of tools to automatically generate reconstruction, their reliability, especially reasons for unreliability, are not...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982036/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3358,
          "title": "Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36990116",
          "author": "Frank Ziemann",
          "description": "Clonal hematopoiesis of indeterminate potential (CHIP) refers to the outgrowth of blood cells from a hematopoietic stem cell (HSC) clone that acquired one or more somatic mutations, leading to a growth advantage compared to wild type HSCs. In the last years this age-associated phenomenon has been extensively studied, and several cohort studies found association between CH and age-related diseases, esp. leukaemia and cardiovascular disease. For patients with CH present with abnormal blood counts,...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36990116/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1436,
          "title": "Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36989374",
          "author": "Lauren Fairchild",
          "description": "In the context of cancer, clonal hematopoiesis of indeterminate potential (CHIP) is associated with the development of therapy-related myeloid neoplasms and shorter overall survival. Cell-free DNA (cfDNA) sequencing is becoming widely adopted for genomic screening of patients with cancer but has not been used extensively to determine CHIP status because of a requirement for matched blood and tumor sequencing. We present an accurate classification approach to determine the CH status from cfDNA...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36989374/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1645,
          "title": "Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982875",
          "author": "Lili Kotmayer",
          "description": "The oral, highly selective Bcl2 inhibitor venetoclax has substantially improved the therapeutic landscape of chronic lymphocytic leukemia (CLL). Despite the remarkable response rates in patients with relapsed/refractory (R/R) disease, acquired resistance is the leading cause of treatment failure, with somatic BCL2 mutations being the predominant genetic drivers underpinning venetoclax resistance. To assess the correlation between disease progression and the most common BCL2 mutations G101V and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982875/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2400,
          "title": "Landscape of <em>BCL2</em> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1640,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982036",
          "author": "Sarah Sandmann",
          "description": "The accurate reconstruction of clonal evolution, including the identification of newly developing, highly aggressive subclones, is essential for the application of precision medicine in cancer treatment. Reconstruction, aiming for correct variant clustering and clonal evolution tree reconstruction, is commonly performed by tedious manual work. While there is a plethora of tools to automatically generate reconstruction, their reliability, especially reasons for unreliability, are not...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982036/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3358,
          "title": "Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982875",
          "author": "Lili Kotmayer",
          "description": "The oral, highly selective Bcl2 inhibitor venetoclax has substantially improved the therapeutic landscape of chronic lymphocytic leukemia (CLL). Despite the remarkable response rates in patients with relapsed/refractory (R/R) disease, acquired resistance is the leading cause of treatment failure, with somatic BCL2 mutations being the predominant genetic drivers underpinning venetoclax resistance. To assess the correlation between disease progression and the most common BCL2 mutations G101V and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982875/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 2415,
          "title": "Landscape of <em>BCL2</em> Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982819",
          "author": "Claudia BƒÉnescu",
          "description": "Myelodysplastic neoplasm (MDS) represents a heterogeneous group of myeloid disorders that originate from the hematopoietic stem and progenitor cells that lead to the development of clonal hematopoiesis. MDS was characterized by an increased risk of transformation into acute myeloid leukemia (AML). In recent years, with the aid of next-generation sequencing (NGS), an increasing number of molecular aberrations were discovered, such as recurrent mutations in FLT3, NPM1, DNMT3A, TP53, NRAS, and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982819/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 1670,
          "title": "The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36982036",
          "author": "Sarah Sandmann",
          "description": "The accurate reconstruction of clonal evolution, including the identification of newly developing, highly aggressive subclones, is essential for the application of precision medicine in cancer treatment. Reconstruction, aiming for correct variant clustering and clonal evolution tree reconstruction, is commonly performed by tedious manual work. While there is a plethora of tools to automatically generate reconstruction, their reliability, especially reasons for unreliability, are not...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36982036/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-29T10:00:00.000Z",
          "wordCount": 3311,
          "title": "Reconstructing Clonal Evolution-A Systematic Evaluation of Current Bioinformatics Approaches",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36978147",
          "author": "Kelly Butler",
          "description": "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptides (APOBECs) are cytosine deaminases involved in innate and adaptive immunity. However, some APOBEC family members can also deaminate host genomes to generate oncogenic mutations. The resulting mutations, primarily signatures 2 and 13, occur in many tumor types and are among the most common mutational signatures in cancer. This review summarizes the current evidence implicating APOBEC3s as major mutators and outlines the exogenous and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36978147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 2124,
          "title": "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36978147",
          "author": "Kelly Butler",
          "description": "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptides (APOBECs) are cytosine deaminases involved in innate and adaptive immunity. However, some APOBEC family members can also deaminate host genomes to generate oncogenic mutations. The resulting mutations, primarily signatures 2 and 13, occur in many tumor types and are among the most common mutational signatures in cancer. This review summarizes the current evidence implicating APOBEC3s as major mutators and outlines the exogenous and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36978147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 2331,
          "title": "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36978147",
          "author": "Kelly Butler",
          "description": "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptides (APOBECs) are cytosine deaminases involved in innate and adaptive immunity. However, some APOBEC family members can also deaminate host genomes to generate oncogenic mutations. The resulting mutations, primarily signatures 2 and 13, occur in many tumor types and are among the most common mutational signatures in cancer. This review summarizes the current evidence implicating APOBEC3s as major mutators and outlines the exogenous and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36978147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 2331,
          "title": "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36978147",
          "author": "Kelly Butler",
          "description": "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptides (APOBECs) are cytosine deaminases involved in innate and adaptive immunity. However, some APOBEC family members can also deaminate host genomes to generate oncogenic mutations. The resulting mutations, primarily signatures 2 and 13, occur in many tumor types and are among the most common mutational signatures in cancer. This review summarizes the current evidence implicating APOBEC3s as major mutators and outlines the exogenous and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36978147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 2306,
          "title": "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36978147",
          "author": "Kelly Butler",
          "description": "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptides (APOBECs) are cytosine deaminases involved in innate and adaptive immunity. However, some APOBEC family members can also deaminate host genomes to generate oncogenic mutations. The resulting mutations, primarily signatures 2 and 13, occur in many tumor types and are among the most common mutational signatures in cancer. This review summarizes the current evidence implicating APOBEC3s as major mutators and outlines the exogenous and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36978147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 2306,
          "title": "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36978147",
          "author": "Kelly Butler",
          "description": "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptides (APOBECs) are cytosine deaminases involved in innate and adaptive immunity. However, some APOBEC family members can also deaminate host genomes to generate oncogenic mutations. The resulting mutations, primarily signatures 2 and 13, occur in many tumor types and are among the most common mutational signatures in cancer. This review summarizes the current evidence implicating APOBEC3s as major mutators and outlines the exogenous and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36978147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 2306,
          "title": "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36978147",
          "author": "Kelly Butler",
          "description": "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptides (APOBECs) are cytosine deaminases involved in innate and adaptive immunity. However, some APOBEC family members can also deaminate host genomes to generate oncogenic mutations. The resulting mutations, primarily signatures 2 and 13, occur in many tumor types and are among the most common mutational signatures in cancer. This review summarizes the current evidence implicating APOBEC3s as major mutators and outlines the exogenous and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36978147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 2245,
          "title": "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36978147",
          "author": "Kelly Butler",
          "description": "Apolipoprotein B mRNA-editing enzyme, catalytic polypeptides (APOBECs) are cytosine deaminases involved in innate and adaptive immunity. However, some APOBEC family members can also deaminate host genomes to generate oncogenic mutations. The resulting mutations, primarily signatures 2 and 13, occur in many tumor types and are among the most common mutational signatures in cancer. This review summarizes the current evidence implicating APOBEC3s as major mutators and outlines the exogenous and...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36978147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-28T10:00:00.000Z",
          "wordCount": 1320,
          "title": "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230405205549&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1806,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230404204750&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1806,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1806,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36971477",
          "author": "G Tjitske Los-de Vries",
          "description": "Large B-cell lymphoma of immune privileged sites (LBCL-IP) arise in immune sanctuaries including the testis and central nervous system. After initially reaching complete response, relapses occur in almost 50% of patients, typically at other immune privileged sites. Resolution of the clonal relationships and evolutionary patterns of LBCL-IP is required to understand the unique clinical behavior. We collected a unique set of 33 primary-relapse LBCL-IP sample pairs and performed next-generation...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36971477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1536,
          "title": "Large B-cell lymphomas of immune privileged sites relapse via parallel clonal evolution from a common progenitor B-cell",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1806,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36971477",
          "author": "G Tjitske Los-de Vries",
          "description": "Large B-cell lymphoma of immune privileged sites (LBCL-IP) arise in immune sanctuaries including the testis and central nervous system. After initially reaching complete response, relapses occur in almost 50% of patients, typically at other immune privileged sites. Resolution of the clonal relationships and evolutionary patterns of LBCL-IP is required to understand the unique clinical behavior. We collected a unique set of 33 primary-relapse LBCL-IP sample pairs and performed next-generation...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36971477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1536,
          "title": "Large B-cell lymphomas of immune privileged sites relapse via parallel clonal evolution from a common progenitor B-cell",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1806,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36971477",
          "author": "G Tjitske Los-de Vries",
          "description": "Large B-cell lymphoma of immune privileged sites (LBCL-IP) arise in immune sanctuaries including the testis and central nervous system. After initially reaching complete response, relapses occur in almost 50% of patients, typically at other immune privileged sites. Resolution of the clonal relationships and evolutionary patterns of LBCL-IP is required to understand the unique clinical behavior. We collected a unique set of 33 primary-relapse LBCL-IP sample pairs and performed next-generation...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36971477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1536,
          "title": "Large B-cell lymphomas of immune privileged sites relapse via parallel clonal evolution from a common progenitor B-cell",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1806,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36971477",
          "author": "G Tjitske Los-de Vries",
          "description": "Large B-cell lymphoma of immune privileged sites (LBCL-IP) arise in immune sanctuaries including the testis and central nervous system. After initially reaching complete response, relapses occur in almost 50% of patients, typically at other immune privileged sites. Resolution of the clonal relationships and evolutionary patterns of LBCL-IP is required to understand the unique clinical behavior. We collected a unique set of 33 primary-relapse LBCL-IP sample pairs and performed next-generation...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36971477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1536,
          "title": "Large B-cell lymphomas of immune privileged sites relapse via parallel clonal evolution from a common progenitor B-cell",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1806,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36971477",
          "author": "G Tjitske Los-de Vries",
          "description": "Large B-cell lymphoma of immune privileged sites (LBCL-IP) arise in immune sanctuaries including the testis and central nervous system. After initially reaching complete response, relapses occur in almost 50% of patients, typically at other immune privileged sites. Resolution of the clonal relationships and evolutionary patterns of LBCL-IP is required to understand the unique clinical behavior. We collected a unique set of 33 primary-relapse LBCL-IP sample pairs and performed next-generation...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36971477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1536,
          "title": "Large B-cell lymphomas of immune privileged sites relapse via parallel clonal evolution from a common progenitor B-cell",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1806,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36971477",
          "author": "G Tjitske Los-de Vries",
          "description": "Large B-cell lymphoma of immune privileged sites (LBCL-IP) arise in immune sanctuaries including the testis and central nervous system. After initially reaching complete response, relapses occur in almost 50% of patients, typically at other immune privileged sites. Resolution of the clonal relationships and evolutionary patterns of LBCL-IP is required to understand the unique clinical behavior. We collected a unique set of 33 primary-relapse LBCL-IP sample pairs and performed next-generation...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36971477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1536,
          "title": "Large B-cell lymphomas of immune privileged sites relapse via parallel clonal evolution from a common progenitor B-cell",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36973454",
          "author": "Verena K√∂rber",
          "description": "Neuroblastoma, the most frequent solid tumor in infants, shows very diverse outcomes from spontaneous regression to fatal disease. When these different tumors originate and how they evolve are not known. Here we quantify the somatic evolution of neuroblastoma by deep whole-genome sequencing, molecular clock analysis and population-genetic modeling in a comprehensive cohort covering all subtypes. We find that tumors across the entire clinical spectrum begin to develop via aberrant mitoses as...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36973454/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1438,
          "title": "Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36971477",
          "author": "G Tjitske Los-de Vries",
          "description": "Large B-cell lymphoma of immune privileged sites (LBCL-IP) arise in immune sanctuaries including the testis and central nervous system. After initially reaching complete response, relapses occur in almost 50% of patients, typically at other immune privileged sites. Resolution of the clonal relationships and evolutionary patterns of LBCL-IP is required to understand the unique clinical behavior. We collected a unique set of 33 primary-relapse LBCL-IP sample pairs and performed next-generation...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36971477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1264,
          "title": "Large B-cell lymphomas of immune privileged sites relapse via parallel clonal evolution from a common progenitor B-cell",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36971477",
          "author": "G Tjitske Los-de Vries",
          "description": "Large B-cell lymphoma of immune privileged sites (LBCL-IP) arise in immune sanctuaries including the testis and central nervous system. After initially reaching complete response, relapses occur in almost 50% of patients, typically at other immune privileged sites. Resolution of the clonal relationships and evolutionary patterns of LBCL-IP is required to understand the unique clinical behavior. We collected a unique set of 33 primary-relapse LBCL-IP sample pairs and performed next-generation...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36971477/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-27T10:00:00.000Z",
          "wordCount": 1240,
          "title": "Large B-cell lymphomas of immune privileged sites relapse via parallel clonal evolution from a common progenitor B-cell",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36966135",
          "author": "Eleanor L Woodward",
          "description": "High hyperdiploid acute lymphoblastic leukemia (HeH ALL), one of the most common childhood malignancies, is driven by nonrandom aneuploidy (abnormal chromosome numbers) mainly comprising chromosomal gains. In this study, we investigate how aneuploidy in HeH ALL arises. Single cell whole genome sequencing of 2847 cells from nine primary cases and one normal bone marrow reveals that HeH ALL generally display low chromosomal heterogeneity, indicating that they are not characterized by chromosomal...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36966135/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230403205647&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-25T10:00:00.000Z",
          "wordCount": 3049,
          "title": "Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36966135",
          "author": "Eleanor L Woodward",
          "description": "High hyperdiploid acute lymphoblastic leukemia (HeH ALL), one of the most common childhood malignancies, is driven by nonrandom aneuploidy (abnormal chromosome numbers) mainly comprising chromosomal gains. In this study, we investigate how aneuploidy in HeH ALL arises. Single cell whole genome sequencing of 2847 cells from nine primary cases and one normal bone marrow reveals that HeH ALL generally display low chromosomal heterogeneity, indicating that they are not characterized by chromosomal...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36966135/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-25T10:00:00.000Z",
          "wordCount": 2985,
          "title": "Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36966135",
          "author": "Eleanor L Woodward",
          "description": "High hyperdiploid acute lymphoblastic leukemia (HeH ALL), one of the most common childhood malignancies, is driven by nonrandom aneuploidy (abnormal chromosome numbers) mainly comprising chromosomal gains. In this study, we investigate how aneuploidy in HeH ALL arises. Single cell whole genome sequencing of 2847 cells from nine primary cases and one normal bone marrow reveals that HeH ALL generally display low chromosomal heterogeneity, indicating that they are not characterized by chromosomal...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36966135/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-25T10:00:00.000Z",
          "wordCount": 2985,
          "title": "Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36966135",
          "author": "Eleanor L Woodward",
          "description": "High hyperdiploid acute lymphoblastic leukemia (HeH ALL), one of the most common childhood malignancies, is driven by nonrandom aneuploidy (abnormal chromosome numbers) mainly comprising chromosomal gains. In this study, we investigate how aneuploidy in HeH ALL arises. Single cell whole genome sequencing of 2847 cells from nine primary cases and one normal bone marrow reveals that HeH ALL generally display low chromosomal heterogeneity, indicating that they are not characterized by chromosomal...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36966135/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-25T10:00:00.000Z",
          "wordCount": 3049,
          "title": "Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36966135",
          "author": "Eleanor L Woodward",
          "description": "High hyperdiploid acute lymphoblastic leukemia (HeH ALL), one of the most common childhood malignancies, is driven by nonrandom aneuploidy (abnormal chromosome numbers) mainly comprising chromosomal gains. In this study, we investigate how aneuploidy in HeH ALL arises. Single cell whole genome sequencing of 2847 cells from nine primary cases and one normal bone marrow reveals that HeH ALL generally display low chromosomal heterogeneity, indicating that they are not characterized by chromosomal...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36966135/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-25T10:00:00.000Z",
          "wordCount": 2985,
          "title": "Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36966135",
          "author": "Eleanor L Woodward",
          "description": "High hyperdiploid acute lymphoblastic leukemia (HeH ALL), one of the most common childhood malignancies, is driven by nonrandom aneuploidy (abnormal chromosome numbers) mainly comprising chromosomal gains. In this study, we investigate how aneuploidy in HeH ALL arises. Single cell whole genome sequencing of 2847 cells from nine primary cases and one normal bone marrow reveals that HeH ALL generally display low chromosomal heterogeneity, indicating that they are not characterized by chromosomal...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36966135/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-25T10:00:00.000Z",
          "wordCount": 2985,
          "title": "Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36966135",
          "author": "Eleanor L Woodward",
          "description": "High hyperdiploid acute lymphoblastic leukemia (HeH ALL), one of the most common childhood malignancies, is driven by nonrandom aneuploidy (abnormal chromosome numbers) mainly comprising chromosomal gains. In this study, we investigate how aneuploidy in HeH ALL arises. Single cell whole genome sequencing of 2847 cells from nine primary cases and one normal bone marrow reveals that HeH ALL generally display low chromosomal heterogeneity, indicating that they are not characterized by chromosomal...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36966135/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-25T10:00:00.000Z",
          "wordCount": 2758,
          "title": "Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 4755,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 4752,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2239,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2182,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2182,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2182,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2182,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2182,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 2156,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36958250",
          "author": "Jana Samarin",
          "description": "Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to better select susceptible cancer entities and stratify patients. Using a large panel of lung cancer cell lines, we identified a set of \"antioxidant-capacity\" biomarkers (ACB), which were tightly repressed, partly by STAT3 and STAT5A/B in sensitive...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36958250/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-23T10:00:00.000Z",
          "wordCount": 1885,
          "title": "Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230402205550&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1696,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230401210003&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1696,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1696,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1692,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1692,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1692,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1692,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1688,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1688,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1688,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36948134",
          "author": "Aybuke Celik",
          "description": "Prostate and ovarian cancers affect the male and female reproductive organs and are among the most common cancers in developing countries. Previous studies have demonstrated that cancer cells have a high rate of aerobic glycolysis that is present in nearly all invasive human cancers and persists even under normoxic conditions. Aerobic glycolysis has been correlated with chemotherapeutic resistance and tumor aggressiveness. These data suggest that mitochondrial dysfunction may confer a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36948134/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-22T10:00:00.000Z",
          "wordCount": 1395,
          "title": "Mitochondrial transplantation: Effects on chemotherapy in prostate and ovarian cancer cells in vitro and in vivo",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230331205841&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1744,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1744,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1744,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1744,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1729,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1729,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1729,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1729,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1729,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1729,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1456,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1813,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36939466",
          "author": "Sharmin Aktar",
          "description": "CONCLUSIONS: There is emerging information on the diagnostic and prognostic value of CTCs in HNSCCs. Evidence also highlights the advantages of various downstream analysis approaches over circulating tumor DNA (ctDNA), such as single-CTC analysis, ex vivo, and in vivo expansion of CTCs. Multiple phenotypic surface markers (cytokeratins, EpCAM, vimentin, etc.), used for CTCs characterization using different immunoassays, could predict disease progression as well as patients' response to treatment...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36939466/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1439,
          "title": "Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36937316",
          "author": "Vincenza Caputo",
          "description": "Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making. It analyzes different blood-circulating biomarkers and circulating tumor DNA (ctDNA) is the preferred one. Nevertheless, tissue biopsy remains the gold standard for molecular evaluation of solid tumors whereas liquid biopsy is a complementary tool in many different clinical settings, such...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36937316/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-20T10:00:00.000Z",
          "wordCount": 1517,
          "title": "Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230330205959&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2138,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2138,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2138,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2138,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2138,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2138,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2138,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2132,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2132,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2124,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2071,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 2056,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36932333",
          "author": "Gianluca Ascolani",
          "description": "CONCLUSIONS: All of this is accessible through a new and interactive Shiny R graphical interface offering the possibility to apply filters helpful in discriminating relevant or potential driver mutations, set up inferential parameters, and visualize the results. The software is available at: github.com/BIMIB-DISCo/LACE.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36932333/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-18T10:00:00.000Z",
          "wordCount": 1420,
          "title": "LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1889,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1889,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1889,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1889,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1889,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1889,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1889,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1889,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1866,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1866,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1919,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1919,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36925092",
          "author": "Gouji Toyokawa",
          "description": "The identification of actionable targets in oncogene-addicted non-small cell lung cancer (NSCLC) has fueled biomarker-directed strategies, especially in advanced stage disease. Despite the undeniable success of molecular targeted therapies, duration of clinical response is relatively short-lived. While extraordinary efforts have defined the complexity of tumor architecture and clonal evolution at the genetic level, not equal interest has been given to the dynamic mechanisms of phenotypic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36925092/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-16T10:00:00.000Z",
          "wordCount": 1646,
          "title": "Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3729,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3729,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3729,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3729,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3729,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3729,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3682,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3729,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3729,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3726,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 3718,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 2450,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 2450,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36921563",
          "author": "Guoqing Zhang",
          "description": "BACKGROUND: Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36921563/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-15T10:00:00.000Z",
          "wordCount": 2423,
          "title": "Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1934,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36914941",
          "author": "Shiyu Song",
          "description": "CONCLUSIONS: On the basis of copy number characteristics, we illustrated tumor heterogeneity in MSS CRC and identified three types of tumor cells with distinct roles in tumor microenvironment. By understanding heterogeneity in the intricate tumor microenvironment, we gained an insight into the mechanisms of tumor evolution, which may support the development of therapeutic strategies.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36914941/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-14T10:00:00.000Z",
          "wordCount": 1895,
          "title": "Single-cell profiling of the copy-number heterogeneity in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 2916,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 2799,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 2793,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 2727,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 2724,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 2441,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1719,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1721,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1721,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1721,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1721,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1721,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1721,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1721,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1721,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1914,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36913406",
          "author": "Magnus J Haughey",
          "description": "The signature of early cancer dynamics on the spatial arrangement of tumour cells is poorly understood, and yet could encode information about how sub-clones grew within the expanding tumour. Novel methods of quantifying spatial tumour data at the cellular scale are required to link evolutionary dynamics to the resulting spatial architecture of the tumour. Here, we propose a framework using first passage times of random walks to quantify the complex spatial patterns of tumour cell population...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36913406/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1677,
          "title": "First passage time analysis of spatial mutation patterns reveals sub-clonal evolutionary dynamics in colorectal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36912175",
          "author": "Zofia M Komar",
          "description": "Accurate models for tumor biology and prediction of drug responses of individual tumors require novel technology to grow tumor tissue ex vivo to maintain tumor growth characteristics in situ. Models containing only tumor cells, without the stromal components of the tumor, are suboptimal for many purposes and are generally problematic because the cells are passed through extensive culture and selection. Therefore, direct culture of (human) tumors is of considerable interest for basic tumor...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36912175/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-13T10:00:00.000Z",
          "wordCount": 1879,
          "title": "Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230329210032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1781,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2013,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 2009,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1474,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36899822",
          "author": "Stamatia C Vorri",
          "description": "The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a higher risk of cardiovascular disease (CVD) and non-acquired immunodeficiency syndrome (AIDS)-defined malignancies. Clonal hematopoiesis (CH) is the acquisition of somatic mutations by the hematopoietic...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36899822/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-11T11:00:00.000Z",
          "wordCount": 1450,
          "title": "Human Immunodeficiency Virus and Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230328210444&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 5723,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 5723,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 5723,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 5716,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 5659,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2346,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2347,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2712,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2079,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2441,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2079,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2441,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2042,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2441,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36879128",
          "author": "Anne-Sophie Hamy",
          "description": "Synchronous bilateral breast cancer (sBBC) occurs after both breasts have been affected by the same germline genetics and environmental exposures. Little evidence exists regarding immune infiltration and response to treatment in sBBCs. Here we show that the impact of the subtype of breast cancer on levels of tumor infiltrating lymphocytes (TILs, n = 277) and on pathologic complete response (pCR) rates (n = 140) differed according to the concordant or discordant subtype of breast cancer of the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36879128/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2042,
          "title": "Evolution of synchronous female bilateral breast cancers and response to treatment",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2382,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36874157",
          "author": "Philipp M√ºller",
          "description": "Loss of the Y chromosome (LoY) is frequently observed in somatic cells of elderly men. However, LoY is highly increased in tumor tissue and correlates with an overall worse prognosis. The underlying causes and downstream effects of LoY are widely unknown. Therefore, we analyzed genomic and transcriptomic data of 13 cancer types (2375 patients) and classified tumors of male patients according to loss or retain of the Y chromosome (LoY or RoY, average LoY fraction: 0.46). The frequencies of LoY...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36874157/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-06T11:00:00.000Z",
          "wordCount": 2382,
          "title": "Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230327210053&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 2303,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1689,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1689,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1689,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1421,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1421,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1421,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1421,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1421,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1358,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36865331",
          "author": "Aaron W Adamson",
          "description": "Background High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free and overall survival. Using a targeted capture of 577 genes involved in DNA damage response and PI3K/AKT/mTOR pathways, we conducted next-generation sequencing of DNA from matched blood and tumor tissue from 71 HGSC participants. In addition, we performed the OncoScan assay...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36865331/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-03T11:00:00.000Z",
          "wordCount": 1358,
          "title": "Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230326205727&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230325210245&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230324205646&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1647,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1887,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1647,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1647,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1647,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1647,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1647,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1644,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1644,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36860424",
          "author": "Youcef Derbal",
          "description": "Genome instability of cancer cells translates into increased entropy and lower information processing capacity, leading to metabolic reprograming toward higher energy states, presumed to be aligned with a cancer growth imperative. Dubbed as the cell adaptive fitness, the proposition postulates that the coupling between cell signaling and metabolism constrains cancer evolutionary dynamics along trajectories privileged by the maintenance of metabolic sufficiency for survival. In particular, the...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36860424/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-03-02T11:00:00.000Z",
          "wordCount": 1599,
          "title": "Cell Adaptive Fitness and Cancer Evolutionary Dynamics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230323205759&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1568,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1854,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200√ó) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1568,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1357,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1357,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1357,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1357,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1334,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1334,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1334,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1334,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36852664",
          "author": "Nam Suk Sim",
          "description": "Lymph node (LN) metastasis is an important factor in determining the treatment and prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Here, we compared the somatic mutational profiles and clonal evolution of primary and metastatic LNs using multiregion sequencing of human papilloma virus (HPV)-positive OPSCC and HPV-negative OPSCC. We performed high-depth whole-exome sequencing (200x) of 76 samples from 18 patients with OPSCC (10 HPV-positive and 8 HPV-negative), including 18 primary...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36852664/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-28T11:00:00.000Z",
          "wordCount": 1310,
          "title": "Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230322205809&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230321205736&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230320205814&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1457,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1422,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1422,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1422,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1422,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1422,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36842901",
          "author": "Abbas Salavaty",
          "description": "Clonal selection and drift drive both normal tissue and cancer development. However, the biological mechanisms and environmental conditions underpinning these processes remain to be elucidated. Clonal selection models are centered in Darwinian evolutionary theory, where some clones with the fittest features are selected and populate the tissue or tumor. We suggest that different subclasses of stem cells, each of which is responsible for a distinct feature of the selection process, share common...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36842901/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-26T11:00:00.000Z",
          "wordCount": 1421,
          "title": "Clonal selection parallels between normal and cancer tissues",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2832,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230319210330&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2832,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230318210719&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2832,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230317205958&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1873,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2832,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1873,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2832,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1873,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2832,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1873,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2832,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1873,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2832,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1873,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2854,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2078,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1873,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2824,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2817,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36835147",
          "author": "Tsz Yin Lau",
          "description": "Whole-genome duplication (WGD) is one of the most common genomic abnormalities in cancers. WGD can provide a source of redundant genes to buffer the deleterious effect of somatic alterations and facilitate clonal evolution in cancer cells. The extra DNA and centrosome burden after WGD is associated with an elevation of genome instability. Causes of genome instability are multifaceted and occur throughout the cell cycle. Among these are DNA damage caused by the abortive mitosis that initially...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36835147/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2081,
          "title": "Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1862,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 2694,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1858,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36841879",
          "author": "Antonio De Falco",
          "description": "Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clonal substructure of tumors from single-cell RNA-seq data. It uses a multichannel segmentation algorithm exploiting the assumption that all the cells in a given copy number clone share the same...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36841879/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1462,
          "title": "A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1813,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36831487",
          "author": "Zheyun Niu",
          "description": "Cancer development follows an evolutionary pattern of \"mutation-selection-adaptation\" detailed by Cancer Evolution and Development (Cancer Evo-Dev), a theory that represents a process of accumulating somatic mutations due to the imbalance between the mutation-promoting force and the mutation-repairing force and retro-differentiation of the mutant cells to cancer initiation cells in a chronic inflammatory microenvironment. The fragile histidine triad (FHIT) gene is a tumor suppressor gene whose...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36831487/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-25T11:00:00.000Z",
          "wordCount": 1541,
          "title": "Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230316210129&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 2092,
          "title": "SMITH: spatially constrained stochastic model for simulation of intra-tumour heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 2089,
          "title": "SMITH: spatially constrained stochastic model for simulation of intra-tumour heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 2020,
          "title": "SMITH: spatially constrained stochastic model for simulation of intra-tumour heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1444,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1444,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1444,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1444,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1444,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1441,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1441,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1441,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1441,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1441,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1441,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1441,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1441,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1440,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1440,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1403,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36825830",
          "author": "Adam Streck",
          "description": "MOTIVATION: Simulations of cancer evolution are highly useful to study the effects of selection and mutation rates on cellular fitness. However, most methods are either lattice-based and cannot simulate realistically-sized tumours, or they omit spatial constraints and lack the clonal dynamics of real-world tumours.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36825830/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-24T11:00:00.000Z",
          "wordCount": 1403,
          "title": "SMITH: Spatially Constrained Stochastic Model for Simulation of Intra-Tumour Heterogeneity",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230315210335&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2643,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230314210149&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2643,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2643,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3323,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1593,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230312210147&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2643,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3323,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1593,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230311200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2623,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2623,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2624,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2624,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2623,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2624,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2624,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2623,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2624,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2624,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2624,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3266,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1591,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1400,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2623,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3265,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1590,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1399,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2622,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3265,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1590,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1401,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2607,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3259,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1584,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1401,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36813776",
          "author": "Seong-Hwan Jun",
          "description": "Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer's proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36813776/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2606,
          "title": "Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 3259,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1584,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807155",
          "author": "Mamiko Sakata-Yanagimoto",
          "description": "In the hematopoietic system of healthy individuals, a phenomenon called clonal hematopoiesis, in which cells acquired somatic mutations are replaced with aging, has been discovered. The frequency of clonal hematopoiesis is higher in patients with solid tumors, than normal individuals. In addition, it is thought that infiltration of inflammatory cells with somatic mutations into cancer tissues may change the tumor microenvironment. Since clonal hematopoiesis is often found incidentally in gene...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807155/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1401,
          "title": "Clonal Hematopoiesis and Solid Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 2811,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807265",
          "author": "De-Chen Lin",
          "description": "Esophageal cancers feature distinct manifestations between and within patients which complicate precision diagnosis, prognosis, and patient care. New genomic and epigenomic research uncovers novel mechanisms underlying both inter- and intra-tumoral heterogeneity in esophageal cancer, with significant biological and translational implications.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807265/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1233,
          "title": "Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36807354",
          "author": "Sijia Cui",
          "description": "Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36807354/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-22T11:00:00.000Z",
          "wordCount": 1601,
          "title": "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230310195643&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230309200611&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230308200648&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230307200654&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1711,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1710,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1710,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1710,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1696,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1696,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1696,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1669,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1669,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1669,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1669,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1669,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36789568",
          "author": "Deborah Caswell",
          "description": "The APOBEC cytidine deaminase enzyme family is linked to mutational signatures identified in cancer. While previous work has provided insights into the role of APOBEC3A and APOBEC3B in mutational processes in cancer, understanding of the mutational signatures induced by other APOBEC family members is limited. In this issue of Cancer Research, Liu and colleagues investigated the role of APOBEC3G (A3G) in bladder cancer. The authors revealed that transgenic expression of A3G in a murine bladder...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36789568/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-15T11:00:00.000Z",
          "wordCount": 1663,
          "title": "Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230306200850&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1779,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1779,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230305200445&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1392,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1779,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230304201225&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1392,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1817,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230303200115&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1392,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36779909",
          "author": "Ryunosuke Saiki",
          "description": "Low-hypodiploid acute lymphoblastic leukemia (LH-ALL) in both children and adults is characterized by biallelic TP53 alterations in virtually all cases. However, in contrast to a common germline origin of the TP53 mutations in pediatric cases, those in adult cases are mostly somatic and are derived from age-related clonal hematopoiesis (ARCH), highlighting the role of TP53-mutant ARCH in the development not only of myeloid leukemogenesis but also of LH-ALL in aged populations. See related...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36779909/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1804,
          "title": "Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1392,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230302215429&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2399,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1392,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2399,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1730,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1392,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2399,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1730,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1391,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2398,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1729,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1391,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2398,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1729,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1391,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2398,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1729,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1391,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2398,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1729,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1391,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2398,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1729,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1391,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2398,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1729,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1364,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2371,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1702,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1364,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2371,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1702,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1364,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2371,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1702,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1364,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2371,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1702,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1364,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2371,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1702,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1364,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2367,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1702,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1364,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2367,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1702,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1298,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2308,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1648,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36778226",
          "author": "Maryam Yousefi",
          "description": "Cancer genomes are almost invariably complex with genomic alterations cooperating during each step of carcinogenesis. In cancers that lack a single dominant oncogene mutation, cooperation between the inactivation of multiple tumor suppressor genes can drive tumor initiation and growth. Here, we shed light on how the sequential acquisition of genomic alterations generates oncogene-negative lung tumors. We couple tumor barcoding with combinatorial and multiplexed somatic genome editing to...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36778226/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1298,
          "title": "Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36777188",
          "author": "Jake Leighton",
          "description": "Single-cell DNA sequencing (scDNA-seq) methods are powerful tools for profiling mutations in cancer cells; however, most genomic regions sequenced in single cells are non-informative. To overcome this issue, we developed a multi-patient-targeted (MPT) scDNA-seq method. MPT involves first performing bulk exome sequencing across a cohort of cancer patients to identify somatic mutations, which are then pooled together to develop a single custom targeted panel for high-throughput scDNA-seq using a...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36777188/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 2308,
          "title": "Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36776363",
          "author": "Kristina Aaltonen",
          "description": "Neuroblastoma is a childhood cancer derived from the sympathetic nervous system. High-risk neuroblastoma patients have a poor overall survival and account for ~15% of childhood cancer deaths. There is thus a need for clinically relevant and authentic models of neuroblastoma that closely resemble the human disease to further interrogate underlying mechanisms and to develop novel therapeutic strategies. Here we review recent developments in patient-derived neuroblastoma xenograft models and in...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36776363/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-13T11:00:00.000Z",
          "wordCount": 1648,
          "title": "Patient-derived models: Advanced tools for precision medicine in neuroblastoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230301200825&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1885,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230228201049&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1885,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1884,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1998,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230227200321&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2232,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1884,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1998,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2232,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1884,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1998,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2232,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1860,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1998,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2232,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1860,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1998,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2232,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1860,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1998,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2232,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1833,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1833,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1833,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1833,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1833,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1833,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1833,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1833,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1685,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1971,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 2205,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1358,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1474,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1800,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36766853",
          "author": "Konstantinos Voskarides",
          "description": "The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36766853/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1334,
          "title": "The Role of <em>TP53</em> in Adaptation and Evolution",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765799",
          "author": "Georgia Gomatou",
          "description": "The development of tyrosine kinase inhibitors (TKIs) targeting the mutant epidermal growth factor receptor (EGFR) protein initiated the success story of targeted therapies in non-small-cell lung cancer (NSCLC). Osimertinib, a third-generation EGFR-TKI, is currently indicated as first-line therapy in patients with NSCLC with sensitizing EGFR mutations, as second-line therapy in patients who present the resistance-associated mutation T790M after treatment with previous EGFR-TKIs, and as adjuvant...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765799/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1450,
          "title": "Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36765687",
          "author": "Robert D Morgan",
          "description": "Women diagnosed with non-mucinous high-grade epithelial ovarian cancer (EOC) in England are often reflex-tested for germline and tumour BRCA1/2 variants. The value of germline BRCA1/2 testing in women diagnosed aged ‚â•80 is questionable. We performed an observational study of all women diagnosed with non-mucinous high-grade EOC who underwent germline and tumour BRCA1/2 testing by the North West of England Genomic Laboratory Hub. A subgroup of women also underwent germline testing using a panel of...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36765687/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-11T11:00:00.000Z",
          "wordCount": 1783,
          "title": "Is Reflex Germline <em>BRCA1/2</em> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatial spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing SCC...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230226200349&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1976,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatial spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing SCC...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1976,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatial spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing SCC...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1976,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatial spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing SCC...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1982,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatial spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing SCC...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1982,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1756,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1709,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36762791",
          "author": "Ryo Tamura",
          "description": "Although the gross and microscopic features of squamous cell carcinoma arising from ovarian mature cystic teratoma (MCT-SCC) vary from case to case, the spatially spreading of genomic alterations within the tumor remains unclear. To clarify the spatial genomic diversity in MCT-SCCs, we performed whole-exome sequencing by collecting 16 samples from histologically different parts of two MCT-SCCs. Both cases showed histological diversity within the tumors (case 1: nonkeratinizing and keratinizing...",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36762791/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230210195718&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-10T11:00:00.000Z",
          "wordCount": 1709,
          "title": "Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230225201023&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1706,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230224200315&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1706,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230223200317&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1706,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230222200051&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1706,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230221200102&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230220200544&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230219200500&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230218200426&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230217200212&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230216200633&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230215200329&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230214200334&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230213200355&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230212200407&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230211200623&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230210195718&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1679,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230209200536&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1642,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230208200032&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1642,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        },
        {
          "id": "pubmed:36747279",
          "author": "Rebecca C Allsopp",
          "description": "CONCLUSIONS: The ReproSeq PGS assay is rapid, at approximately $120 per sample, providing both a sCNA profile and estimation of the tumor DNA fraction from limiting cfDNA template (300pg) and individual CTCs. The approach could be used to examine the copy number landscape over time to guide treatment decisions, support future trial designs, and be applied to low volume blood spot samples enabling remote monitoring.",
          "link": "https://pubmed.ncbi.nlm.nih.gov/36747279/?utm_source=axios&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1HuCGFZSJIJipW3YKC8lKs0LOntnvC4VTlDPv37z3kpJCsGYKs&fc=20220608010801&ff=20230207200158&v=2.17.9.post6+86293ac",
          "publishedOn": "2023-02-07T11:00:00.000Z",
          "wordCount": 1642,
          "title": "A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA",
          "imageUrl": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image.png"
        }
      ]
    },
    {
      "title": "Tools of the Trade\n  | Nature Reviews Cancer",
      "feedUrl": "https://rss.app/feeds/MObijZlQoPFbWbsL.xml",
      "siteUrl": "https://www.nature.com/nrc/articles?type=tools-of-the-trade",
      "articles": []
    }
  ],
  "cliVersion": "1.15.1"
}